A	DT	O
``	``	O
HAPPINESS	NNP	O
GENE	NNP	O
''	''	O
that	WDT	B-REL
has	VBZ	I-REL
a	DT	I-REL
strong	JJ	I-REL
influence	NN	I-REL
on	IN	I-REL
how	WRB	O
satisfied	JJ	O
people	NNS	O
are	VBP	O
with	IN	O
their	PRP$	O
lives	NNS	O
has	VBZ	O
been	VBN	O
discovered	VBN	O

Researchers	NNS	O
have	VBP	O
identified	VBN	O
a	DT	O
``	``	O
happiness	NN	O
gene	NN	O
''	''	O
that	WDT	O
makes	VBZ	B-REL
people	NNS	O
more	RBR	O
likely	JJ	O
to	TO	O
feel	VB	O
satisfied	JJ	O
with	IN	O
their	PRP$	O
lives	NNS	O

Findings	NNS	O
indicate	VBP	O
that	IN	O
an	DT	O
organization	NN	O
's	POS	O
support	NN	O
for	IN	O
work-home	NN	O
issues	NNS	O
has	VBZ	B-REL
a	DT	I-REL
significant	JJ	I-REL
impact	NN	I-REL
on	IN	O
employee	NN	O
's	POS	O
well-being	NN	O

A	DT	O
supportive	JJ	O
work-home	NN	O
culture	NN	O
is	VBZ	B-REL
significantly	RB	I-REL
associated	VBN	I-REL
with	IN	I-REL
lower	JJR	O
levels	NNS	O
of	IN	O
psychosomatic	JJ	O
strain	NN	O
among	IN	O
employees	NNS	O

Even	RB	O
if	IN	O
options	NNS	O
such	JJ	O
as	IN	O
flexible	JJ	O
working	VBG	O
hours	NNS	O
and	CC	O
help	VB	O
with	IN	O
childcare	NN	O
are	VBP	O
available	JJ	O
to	TO	B-REL
employees	NNS	O
,	,	O
this	DT	O
does	VBZ	B-REL
little	JJ	I-REL
to	TO	O
reduce	VB	B-REL
stress	NN	O
unless	IN	O
there	EX	O
is	VBZ	O
positive	JJ	O
endorsement	NN	O
from	IN	O
managers	NNS	O

The	DT	O
advice	NN	O
given	VBN	O
by	IN	O
the	DT	O
allergy	NN	O
clinic	NN	O
to	TO	O
avoid	VB	O
nuts	NNS	O
had	VBD	B-REL
a	DT	I-REL
huge	JJ	I-REL
impact	NN	I-REL
on	IN	O
families	NNS	O
'	POS	O
lives	NNS	O

it	PRP	O
-LSB-	-LRB-	O
nut	NN	O
allergy	NN	O
-RSB-	-RRB-	O
imposes	VBZ	B-REL
social	JJ	O
barriers	NNS	O

Their	PRP$	O
-LSB-	-LRB-	O
women	NNS	O
-RSB-	-RRB-	O
psychological	JJ	O
health	NN	O
is	VBZ	B-REL
adversely	RB	I-REL
affected	VBN	I-REL
by	IN	O
commuting	VBG	O

Commuting	VBG	O
has	VBZ	B-REL
an	DT	I-REL
important	JJ	I-REL
detrimental	JJ	I-REL
effect	NN	I-REL
on	IN	O
the	DT	O
psychological	JJ	O
health	NN	O
of	IN	O
women	NNS	O

Commuting	VBG	O
has	VBZ	B-REL
a	DT	I-REL
negative	JJ	I-REL
effect	NN	I-REL
on	IN	O
women	NNS	O
's	POS	O
mental	JJ	O
health	NN	O

Women	NNS	O
suffer	VBP	O
more	JJR	B-REL
stress	NN	O
from	IN	O
their	PRP$	O
daily	JJ	O
commute	NN	O
than	IN	O
men	NNS	O

The	DT	O
stress	NN	O
of	IN	O
daily	JJ	O
commuting	VBG	O
damages	NNS	B-REL
the	DT	O
mental	JJ	O
health	NN	O
of	IN	O
women	NNS	O

Father	NNP	O
absence	NN	O
is	VBZ	O
associated	VBN	B-REL
with	IN	I-REL
later	JJ	O
puberty	NN	O
,	,	O
later	RB	O
marriage	NN	O
,	,	O
but	CC	O
earlier	JJR	O
reproduction	NN	O

Father	NNP	O
absence	NN	O
before	IN	O
the	DT	O
age	NN	O
of	IN	O
seven	CD	O
is	VBZ	O
associated	VBN	B-REL
with	IN	I-REL
early	JJ	O
reproduction	NN	O

Boys	NNS	O
with	IN	O
absent	JJ	O
fathers	NNS	O
more	RBR	B-REL
likely	JJ	I-REL
to	TO	O
be	VB	O
young	JJ	O
fathers	NNS	O

Boys	NNS	O
with	IN	O
absence	NN	O
fathers	NNS	O
likely	JJ	B-REL
to	TO	I-REL
have	VB	O
children	NNS	O
earlier	RBR	O

The	DT	O
results	NNS	O
highlight	VBP	O
the	DT	B-REL
importance	NN	I-REL
of	IN	O
collagen	NN	O
IV	CD	O
and	CC	O
Bms	NNS	O
in	IN	O
normal	JJ	O
tendon	NN	O
function	NN	O
.	.	O

The	DT	O
existence	NN	O
of	IN	O
a	DT	O
novel	JJ	O
tendon	NN	O
BM-epithelium	NN	O
that	WDT	O
is	VBZ	O
required	VBN	B-REL
to	TO	I-REL
prevent	VB	I-REL
adhesion	NN	O
formation	NN	O
.	.	O

Receipt	NN	O
of	IN	O
alcohol	NN	O
industry	NN	O
sponsorship	NN	O
was	VBD	B-REL
associated	VBN	I-REL
with	IN	I-REL
higher	JJR	O
AUDIT	NN	O
scores	NNS	O
.	.	O

Receipt	NN	O
of	IN	B-REL
alcohol	NN	O
industry	NN	O
sponsorship	NN	O
was	VBD	B-REL
predictive	JJ	I-REL
of	IN	O
higher	JJR	O
AUDIT	NN	O
scores	NNS	O
.	.	O

Alcohol	NN	O
industry	NN	O
sponsorship	NN	O
of	IN	O
sport	NN	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
more	JJR	O
hazardous	JJ	O
drinking	NN	O
in	IN	O
sportspeople	NN	O
compared	VBN	O
to	TO	O
non-alcohol	JJ	O
sponsorship	NN	O
.	.	O

The	DT	O
north-south	JJ	O
divide	NN	O
in	IN	O
population	NN	O
wide	JJ	O
all	DT	O
cause	VBP	O
mortality	NN	O
has	VBZ	B-REL
been	VBN	I-REL
both	DT	I-REL
substantial	JJ	I-REL
and	CC	I-REL
persistent	JJ	I-REL
over	IN	O
the	DT	O
past	JJ	O
four	CD	O
decades	NNS	O
since	IN	O
1965	CD	O
in	IN	O
England	NNP	O
.	.	O

Inequalities	NNS	O
in	IN	O
all	DT	O
cause	NN	O
mortality	NN	O
in	IN	O
the	DT	O
north-south	JJ	O
divide	NN	O
were	VBD	B-REL
severe	JJ	I-REL
and	CC	I-REL
persistent	JJ	I-REL
over	IN	O
the	DT	O
four	CD	O
decades	NNS	O
from	IN	O
1965	CD	O
to	TO	O
2008	CD	O
.	.	O

Chance	NN	O
of	IN	O
dying	VBG	O
early	RB	O
20	CD	B-REL
%	NN	I-REL
higher	JJR	I-REL
in	IN	I-REL
north	RB	O
than	IN	O
south	NN	O
of	IN	O
England	NNP	O
.	.	O

37000	CD	O
more	JJR	B-REL
people	NNS	O
go	VBP	O
to	TO	O
their	PRP$	O
graves	NNS	O
early	RB	O
in	IN	O
the	DT	O
North	NNP	O
compared	VBN	O
with	IN	O
the	DT	O
South	NNP	O
.	.	O

Northerners	NNS	O
'	POS	O
20	CD	O
%	NN	O
more	RBR	B-REL
likely	JJ	I-REL
to	TO	O
die	VB	O
under	IN	O
75	CD	O
'	''	O
than	IN	O
southerners	NNS	O
.	.	O

People	NNS	O
in	IN	O
the	DT	O
north	NN	O
are	VBP	O
20	CD	O
per	IN	O
cent	NN	O
more	RBR	B-REL
likely	JJ	I-REL
to	TO	O
die	VB	O
before	IN	O
the	DT	O
age	NN	O
of	IN	O
75	CD	O
than	IN	O
those	DT	O
in	IN	O
the	DT	O
south	NN	O
.	.	O

The	DT	O
health	NN	O
divide	NN	O
between	IN	B-REL
the	DT	O
North	NNP	O
and	CC	O
South	NNP	O
of	IN	O
the	DT	O
country	NN	O
is	VBZ	O
at	IN	O
its	PRP$	O
widest	JJS	O
for	IN	O
40	CD	O
years	NNS	O
and	CC	O
is	VBZ	O
claiming	VBG	O
the	DT	O
lives	NNS	O
of	IN	O
tens	NNS	O
of	IN	O
thousands	NNS	O
of	IN	O
people	NNS	O
before	IN	O
their	PRP$	O
time	NN	O
.	.	O

The	DT	O
chances	NNS	B-REL
of	IN	O
dying	VBG	O
early	RB	O
are	VBP	O
a	DT	O
fifth	JJ	O
higher	JJR	O
in	IN	O
the	DT	O
North	NN	O
of	IN	O
England	NNP	O
compared	VBN	O
with	IN	O
the	DT	O
South	NNP	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
recovery	NN	B-REL
of	IN	O
KATP	NN	O
channel	NN	O
activity	NN	O
in	IN	O
Beta-cells	NNS	O
from	IN	O
patients	NNS	O
with	IN	O
CHI	NN	O
following	VBG	O
incubation	NN	O
with	IN	O
chemical	NN	O
mediators	NNS	O
,	,	O
kinase	NN	O
activators	NNS	O
,	,	O
and	CC	O
reduced	VBD	O
temperature	NN	O
to	TO	O
increase	VB	O
trafficking	NN	O
of	IN	O
the	DT	O
channels	NNS	O
to	TO	O
the	DT	O
cell	NN	O
membrane	NN	O

Here	RB	O
,	,	O
we	PRP	O
report	VBP	O
the	DT	O
first	JJ	O
cases	NNS	O
of	IN	O
recovery	NN	B-REL
of	IN	O
defective	JJ	O
KATP	NN	O
channels	NNS	O
in	IN	O
human	JJ	O
Beta-cells	NNS	O
using	VBG	O
modified	VBN	O
cell	NN	O
culture	NN	O
conditions	NNS	O

The	DT	O
association	NN	B-REL
between	IN	I-REL
social	JJ	O
cohesion	NN	O
and	CC	O
area	NN	O
deprivation	NN	O
is	VBZ	O
consistently	RB	O
strong	JJ	O
.	.	O

Multiculturalism	NN	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
strengthening	VBG	O
the	DT	O
ties	NNS	O
between	IN	O
different	JJ	O
ethnic	JJ	O
groups	NNS	O
,	,	O
according	VBG	O
to	TO	O
an	DT	O
extensive	JJ	O
study	NN	O
of	IN	O
English	NNP	O
data	NNS	O
.	.	O

The	DT	O
increase	NN	B-REL
and	CC	O
wide-spread	JJ	O
use	NN	O
of	IN	O
mobile	JJ	O
phones	NNS	O
,	,	O
which	WDT	O
in	IN	O
some	DT	O
studies	NNS	O
was	VBD	O
associated	VBN	O
with	IN	O
increased	VBN	O
brain	NN	O
cancer	NN	O
risk	NN	O
,	,	O
has	VBZ	B-REL
not	RB	I-REL
led	VBN	I-REL
to	TO	I-REL
a	DT	I-REL
noticeable	JJ	I-REL
increase	NN	O
in	IN	O
the	DT	O
incidence	NN	O
of	IN	O
brain	NN	O
cancer	NN	O
in	IN	O
England	NNP	O
between	IN	O
1998	CD	O
and	CC	O
2007	CD	O
.	.	O

The	DT	O
increased	VBN	O
use	NN	O
of	IN	O
mobile	JJ	O
phone	NN	O
between	IN	O
1985	CD	O
and	CC	O
2003	CD	O
has	VBZ	B-REL
not	RB	I-REL
led	VBN	I-REL
to	TO	I-REL
a	DT	I-REL
noticeable	JJ	I-REL
change	NN	I-REL
in	IN	O
the	DT	O
incidence	NN	O
of	IN	O
brain	NN	O
cancer	NN	O
in	IN	O
England	NNP	O
between	IN	O
1998	CD	O
and	CC	O
2007	CD	O
.	.	O

Mobile	NNP	O
phone	NN	O
use	NN	O
not	RB	B-REL
related	JJ	I-REL
to	TO	I-REL
increased	VBN	I-REL
brain	NN	O
cancer	NN	O
risk	NN	O
.	.	O

Using	VBG	O
mobile	JJ	O
phones	NNS	O
does	VBZ	B-REL
not	RB	I-REL
increase	VB	I-REL
your	PRP$	I-REL
cancer	NN	O
risk	NN	O
.	.	O

Mobile	NNP	O
phones	NNS	O
do	VBP	B-REL
not	RB	I-REL
cause	VB	I-REL
brain	NN	O
tumours	NNS	O
.	.	O

The	DT	O
key	JJ	O
findings	NNS	O
of	IN	O
the	DT	O
present	JJ	O
study	NN	O
were	VBD	O
associations	NNS	B-REL
between	IN	I-REL
baseline	NN	O
HAPPI	NN	O
score	NN	O
and	CC	O
both	DT	O
ISS	NNP	O
Activation	NN	O
and	CC	O
Conflict	NN	O
after	IN	O
4	CD	O
weeks	NNS	O
,	,	O
independently	RB	O
of	IN	O
baseline	NN	O
symptoms	NNS	O
and	CC	O
potential	JJ	O
confounds	NNS	O
.	.	O

The	DT	O
HAPPI	NNP	O
was	VBD	O
positively	RB	O
,	,	O
independently	RB	O
associated	VBN	B-REL
with	IN	I-REL
activation	NN	O
and	CC	O
conflict	NN	O
after	IN	O
4	CD	O
weeks	NNS	O
.	.	O

The	DT	O
future	JJ	O
mood	NN	O
swings	NNS	O
of	IN	O
people	NNS	O
with	IN	O
bipolar	JJ	O
disorder	NN	O
can	MD	B-REL
be	VB	I-REL
predicted	VBN	I-REL
by	IN	O
their	PRP$	O
current	JJ	O
thoughts	NNS	O
and	CC	O
behaviour	NN	O
.	.	O

...	:	O
HIV	NN	O
protease	NN	O
inhibitor	NN	O
lopinavir	NN	O
induces	VBZ	B-REL
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
levels	NNS	O
of	IN	O
the	DT	O
RNASEL	NN	O
protein	NN	O
in	IN	O
HPV-positive	JJ	O
cervical	JJ	O
carcinoma	NN	O
cells	NNS	O
and	CC	O
in	IN	O
stable	JJ	O
HPV16	NN	O
E6/E7	NN	O
transfected	VBN	O
human	JJ	O
keratinocytes	NNS	O
...	:	O

...	:	O
These	DT	O
data	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
the	DT	O
toxicity	NN	B-REL
of	IN	I-REL
lopinavir	NN	I-REL
against	IN	I-REL
HPV-positive	JJ	O
cervical	JJ	O
carcinoma	NN	O
cells	NNS	O
being	VBG	O
related	VBN	O
to	TO	O
its	PRP$	O
ability	NN	O
to	TO	O
block	VB	O
viral	JJ	O
proteasome	NN	O
activation	NN	O
and	CC	O
induce	VB	O
an	DT	O
up-regulation	NN	O
of	IN	O
the	DT	O
antiviral	JJ	O
protein	NN	O
RNASEL	NN	O
...	:	O

...	:	O
the	DT	O
antiviral	JJ	O
drug	NN	O
attacks	NNS	B-REL
HPV	NN	O
by	IN	O
switching	VBG	O
on	IN	O
a	DT	O
natural	JJ	O
viral	JJ	O
defence	NN	O
system	NN	O
in	IN	O
infected	JJ	O
cells	NNS	O
...	:	O

...	:	O
the	DT	O
human	JJ	O
papilloma	NN	O
virus	NN	O
can	MD	B-REL
be	VB	I-REL
eliminated	VBN	I-REL
by	IN	I-REL
drugs	NNS	O
that	WDT	O
tackle	VBP	O
HIV	NN	O
...	:	O

...	:	O
the	DT	O
medication	NN	O
attacks	NNS	B-REL
and	CC	I-REL
kills	VBZ	I-REL
a	DT	O
virus	NN	O
which	WDT	O
puts	VBZ	O
cells	NNS	O
at	IN	O
risk	NN	O
of	IN	O
becoming	VBG	O
cancerous	JJ	O
...	:	O

...	:	O
the	DT	O
drug	NN	O
lopinavir	NN	O
kills	VBZ	B-REL
cells	NNS	O
infecd	VBN	O
by	IN	O
the	DT	O
human	JJ	O
papilloma	NN	O
virus	NN	O
...	:	O

as	IN	O
a	DT	B-REL
crucial	JJ	I-REL
effector	NN	I-REL
molecule	NN	O
during	IN	O
infections	NNS	O
of	IN	O
the	DT	O
intestine	NN	O
.	.	O

Muc5ac	NN	O
,	,	O
as	IN	O
a	DT	B-REL
direct	JJ	I-REL
and	CC	I-REL
critical	JJ	I-REL
mediator	NN	I-REL
of	IN	O
resistance	NN	O
during	IN	O
intestinal	JJ	O
nematode	NN	O
infection	NN	O
.	.	O

PCR	NN	O
offers	VBZ	O
a	DT	O
more	RBR	B-REL
sensitive	JJ	I-REL
methodology	NN	O
than	IN	O
culture	NN	O
for	IN	O
the	DT	O
detection	NN	O
of	IN	O
Aspergillus	JJ	O
spp	NN	O
.	.	O

a	DT	O
new	JJ	O
test	NN	O
that	WDT	O
can	MD	B-REL
...	:	O
better	JJR	B-REL
diagnose	VB	I-REL
Aspergillus	JJ	O
infection	NN	O
.	.	O

Implant	NN	O
jab	NN	O
could	MD	B-REL
solve	VB	I-REL
the	DT	O
misery	NN	O
of	IN	O
back	RB	O
pain	NN	O
.	.	O

The	DT	O
surgery-free	JJ	O
solution	NN	B-REL
to	TO	O
your	PRP$	O
bad	JJ	O
back	NN	O
...	:	O
a	DT	O
jab	NN	O
of	IN	O
gel	NN	O
.	.	O

Fluid	NN	O
jab	NN	O
in	IN	O
spine	NN	O
cures	NNS	B-REL
disc	NN	O
pain	NN	O
.	.	O

Gel	NN	O
to	TO	B-REL
wipe	VB	I-REL
out	RP	I-REL
the	DT	O
misery	NN	O
of	IN	O
back	RB	O
pain	NN	O
for	IN	O
millions	NNS	O
.	.	O

New	NNP	O
gel	NN	O
could	MD	B-REL
solve	VB	I-REL
back	RB	O
pain	NN	O
.	.	O

MKK4	NN	O
regulates	VBZ	B-REL
Cx43	NN	O
expression	NN	O
in	IN	O
cardiomyocytes	NNS	O

Knockdown	NNP	O
of	IN	O
MKK4	NN	O
expression	NN	O
or	CC	O
inhibition	NN	O
of	IN	O
its	PRP$	O
kinase	NN	O
activity	NN	O
in	IN	O
neonatal	JJ	O
rat	NN	O
cardiomyocytes	NNS	O
-LRB-	-LRB-	O
NRCMs	NNS	O
-RRB-	-RRB-	O
significantly	RB	B-REL
reduced	VBD	I-REL
phenylephrine-induced	JJ	O
Cx43	NN	O
expression	NN	O

Enzyme	NN	O
prevents	VBZ	B-REL
fatal	JJ	O
heart	NN	O
condition	NN	O
associated	VBN	O
with	IN	O
athletes	NNS	O

...	:	O
Men	NN	O
and	CC	O
women	NNS	O
who	WP	O
leave	VBP	O
school	NN	O
without	IN	O
any	DT	O
qualifications	NNS	O
may	MD	O
be	VB	O
able	JJ	O
to	TO	O
`	``	O
catch	VB	O
up	RP	O
'	''	O
to	TO	O
some	DT	O
extent	NN	O
with	IN	O
more	JJR	O
qualified	JJ	O
people	NNS	O
in	IN	O
terms	NNS	O
of	IN	O
lowering	VBG	B-REL
their	PRP$	I-REL
CHD	NN	I-REL
risk	NN	I-REL
,	,	O
if	IN	O
they	PRP	O
obtain	VBP	O
higher	JJR	O
qualifications	NNS	O
later	RB	O
on	IN	O
in	IN	O
life	NN	O
...	:	O

...	:	O
Men	NN	O
and	CC	O
women	NNS	O
who	WP	O
leave	VBP	O
school	NN	O
without	IN	O
any	DT	O
qualifications	NNS	O
may	MD	O
be	VB	O
able	JJ	O
to	TO	O
`	``	O
catch	VB	O
up	RP	O
'	''	O
to	TO	O
some	DT	O
extent	NN	O
with	IN	O
more	JJR	O
qualified	JJ	O
people	NNS	O
in	IN	O
terms	NNS	O
of	IN	O
lowered	JJ	B-REL
CHD	NN	I-REL
risk	NN	I-REL
...	:	O

...	:	O
do	VB	O
well	RB	O
at	IN	O
school	NN	O
to	TO	B-REL
avoid	VB	I-REL
heart	NN	O
disease	NN	O
...	:	O

...	:	O
loss	NN	O
of	IN	O
E-cadherin	NN	O
has	VBZ	B-REL
effects	NNS	I-REL
not	RB	I-REL
only	RB	I-REL
confined	VBN	O
to	TO	O
cellular	JJ	O
adhesion	NN	O
but	CC	O
also	RB	O
on	IN	O
the	DT	O
general	JJ	O
biology	NN	O
of	IN	O
ES	NN	O
cells	NNS	O
...	:	O

...	:	O
loss	NN	O
of	IN	O
E-cadherin	NN	O
in	IN	O
mouse	NN	O
ES	NN	O
cells	NNS	O
leads	VBZ	B-REL
to	TO	I-REL
significant	JJ	O
transcript	NN	O
alterations	NNS	O
...	:	O

...	:	O
is	VBZ	O
also	RB	O
responsible	JJ	B-REL
for	IN	I-REL
many	JJ	O
other	JJ	O
important	JJ	O
functions	NNS	O
of	IN	O
cells	NNS	O
...	:	O

large	JJ	O
proportion	NN	O
of	IN	O
the	DT	O
heritability	NN	O
estimate	NN	O
of	IN	O
intelligence	NN	O
in	IN	O
middle	JJ	O
to	TO	O
older	JJR	O
adulthood	NN	O
can	MD	B-REL
be	VB	I-REL
traced	VBN	O
to	TO	O
biological	JJ	O
variation	NN	O
using	VBG	O
SNP	NN	O
data	NNS	O

a	DT	O
substantial	JJ	O
proportion	NN	O
of	IN	O
individual	JJ	O
differences	NNS	O
in	IN	O
human	JJ	O
intelligence	NN	O
is	VBZ	B-REL
due	JJ	I-REL
to	TO	I-REL
genetic	JJ	O
variation	NN	O

direct	JJ	O
biological	JJ	O
evidence	NN	O
for	IN	O
a	DT	O
genetic	JJ	O
contribution	NN	B-REL
to	TO	I-REL
people	NNS	O
's	POS	O
intelligence	NN	O

HALF	NN	O
OF	IN	O
YOUR	JJ	O
INTELLIGENCE	NN	O
COMES	VBZ	B-REL
FROM	IN	I-REL
YOUR	JJ	O
PARENTS	NNS	O

Genetic	JJ	O
factors	NNS	O
explain	VBP	B-REL
about	IN	O
half	PDT	O
the	DT	O
differences	NNS	O
between	IN	O
individual	JJ	O
people	NNS	O
's	POS	O
intelligence	NN	O

Genetic	JJ	O
differences	NNS	O
between	IN	O
people	NNS	O
account	VBP	B-REL
for	IN	I-REL
up	RB	O
to	TO	O
half	NN	O
of	IN	O
the	DT	O
variation	NN	O
in	IN	O
intelligence	NN	O

...	:	O
we	PRP	O
used	VBD	O
next-generation	JJ	O
sequencing	NN	O
technology	NN	O
to	TO	O
identify	VB	O
a	DT	O
hexanucleotide	NN	O
repeat	NN	O
expansion	NN	O
within	IN	O
the	DT	B-REL
C9ORF72	NN	O
gene	NN	O
as	IN	B-REL
the	DT	O
cause	NN	B-REL
of	IN	I-REL
chromosome	NN	O
9p21-linked	JJ	O
ALS-FTD	NN	O
...	:	O

...	:	O
this	DT	O
repeat	NN	O
expansion	NN	O
segregates	VBZ	B-REL
perfectly	RB	I-REL
with	IN	I-REL
disease	NN	O
in	IN	O
the	DT	O
Finnish	JJ	O
population	NN	O
...	:	O

...	:	O
new	JJ	O
gene	NN	O
linked	VBN	B-REL
to	TO	I-REL
familial	JJ	O
motor	NN	O
neuron	NN	O
disease	NN	O
...	:	O

...	:	O
a	DT	O
Gwent	NNP	O
family	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
motor	NN	O
neurone	NN	O
disease	NN	O
-LRB-	-LRB-	O
MND	NN	O
-RRB-	-RRB-	O
has	VBZ	O
helped	VBN	O
scientists	NNS	O
from	IN	O
Cardiff	NNP	O
University	NNP	O
find	VB	O
a	DT	O
``	``	O
new	JJ	O
gene	NN	O
''	''	O
linked	VBN	B-REL
to	TO	I-REL
the	DT	I-REL
disease	NN	O
...	:	O

three	CD	O
antiviral	JJ	O
agents	NNS	O
we	PRP	O
studied	VBD	O
significantly	RB	B-REL
reduced	VBN	I-REL
the	DT	O
levels	NNS	O
of	IN	O
Ab	NN	O
and	CC	O
P-tau	NN	O

antiviral	JJ	O
agents	NNS	O
reduce	VB	B-REL
greatly	RB	O
Ab	NN	O
and	CC	O
P-tau	NN	O
accumulation	NN	O
in	IN	O
HSV1-infected	JJ	O
cells	NNS	O

Antiviral	JJ	O
drugs	NNS	O
used	VBN	O
to	TO	O
target	VB	O
the	DT	O
herpes	NN	O
virus	NN	O
could	MD	B-REL
be	VB	I-REL
effective	JJ	I-REL
at	IN	I-REL
slowing	VBG	I-REL
the	DT	O
progression	NN	O
of	IN	O
Alzheimer	NN	O
's	POS	O
disease	NN	O

drugs	NNS	O
such	JJ	O
as	IN	O
acyclovir	NN	O
...	:	O
are	VBP	B-REL
capable	JJ	I-REL
of	IN	I-REL
reducing	VBG	I-REL
the	DT	O
build-up	NN	O
of	IN	O
damaging	JJ	O
proteins	NNS	O
that	WDT	O
are	VBP	O
associated	VBN	O
with	IN	O
the	DT	O
commonest	JJS	O
form	NN	O
of	IN	O
dementia	NN	O

...	:	O
we	PRP	O
found	VBD	O
that	IN	O
offering	VBG	O
a	DT	O
12-week	JJ	O
yoga	NN	O
program	NN	O
to	TO	B-REL
adults	NNS	O
with	IN	O
chronic	JJ	O
or	CC	O
recurrent	JJ	O
low	JJ	O
back	RB	O
pain	NN	O
led	VBD	B-REL
to	TO	O
greater	JJR	B-REL
improvements	NNS	I-REL
in	IN	O
back	JJ	O
function	NN	O
than	IN	O
usual	JJ	O
care	NN	O
for	IN	O
up	RB	O
to	TO	O
12	CD	O
months	NNS	O
...	:	O

...	:	O
offering	VBG	O
a	DT	O
12-week	JJ	O
yoga	NN	O
program	NN	O
to	TO	B-REL
adults	NNS	O
with	IN	O
chronic	JJ	O
or	CC	O
recurrent	JJ	O
low	JJ	O
back	RB	O
pain	NN	O
led	VBD	B-REL
to	TO	O
greater	JJR	B-REL
improvements	NNS	I-REL
in	IN	O
back	JJ	O
function	NN	O
than	IN	O
did	VBD	O
usual	JJ	O
care	NN	O
...	:	O

...	:	O
yoga	NN	O
can	MD	B-REL
provide	VB	I-REL
more	RBR	I-REL
effective	JJ	I-REL
treatment	NN	I-REL
for	IN	I-REL
chronic	JJ	I-REL
lower	JJR	I-REL
back	RB	I-REL
pain	NN	I-REL
than	IN	I-REL
more	JJR	O
conventional	JJ	O
methods	NNS	O
...	:	O

...	:	O
YOGA	NN	O
`	``	O
IS	VBZ	O
BETTER	NNP	B-REL
AT	IN	I-REL
TREATING	NNP	I-REL
A	NNP	I-REL
BAD	NNP	I-REL
BACK	RB	I-REL
THAN	IN	O
GOING	JJ	O
TO	TO	O
THE	DT	O
DOCTOR	NN	O
'	''	O
...	:	O

...	:	O
YOGA	NN	O
is	VBZ	B-REL
better	RBR	I-REL
for	IN	I-REL
chronic	JJ	I-REL
back	JJ	I-REL
ache	NN	O
than	IN	O
standard	JJ	O
NHS	NN	O
treatments	NNS	O
...	:	O

...	:	O
cure	NN	B-REL
back	RB	O
pain	NN	O
...	:	O

...	:	O
yoga	NN	O
is	VBZ	B-REL
more	RBR	I-REL
effective	JJ	I-REL
at	IN	I-REL
alleviating	VBG	I-REL
lower	JJR	O
back	RB	O
pain	NN	O
...	:	O

...	:	O
Yoga	NN	O
is	VBZ	O
more	RBR	B-REL
effective	JJ	I-REL
in	IN	I-REL
helping	VBG	I-REL
people	NNS	I-REL
with	IN	I-REL
lower	JJR	I-REL
back	RB	I-REL
pain	NN	I-REL
to	TO	I-REL
become	VB	I-REL
more	RBR	O
mobile	JJ	O
than	IN	O
the	DT	O
conventional	JJ	O
treatments	NNS	O
GPs	NNS	O
offer	VBP	O
...	:	O

...	:	O
a	DT	B-REL
12-week	JJ	O
yoga	NN	O
class	NN	O
led	VBD	B-REL
to	TO	I-REL
a	DT	O
small	JJ	B-REL
improvement	NN	I-REL
in	IN	I-REL
how	WRB	I-REL
well	RB	I-REL
participants	NNS	O
could	MD	O
perform	VB	O
daily	JJ	O
activities	NNS	O
...	:	O

A	DT	O
brief	JJ	O
TCBT	NN	O
or	CC	O
exercise	NN	O
program	NN	O
was	VBD	O
associated	VBN	B-REL
with	IN	O
substantial	JJ	O
,	,	O
significant	JJ	O
,	,	O
clinically	RB	O
meaningful	JJ	O
improvements	NNS	O
in	IN	O
self-rated	JJ	O
global	JJ	O
health	NN	O

TCBT	NN	O
was	VBD	O
associated	VBN	B-REL
with	IN	O
substantial	JJ	O
,	,	O
statistically	RB	O
significant	JJ	O
,	,	O
and	CC	O
sustained	JJ	O
improvements	NNS	O
in	IN	O
patient	NN	O
global	JJ	O
assessment	NN	O

Talking	VBG	O
therapy	NN	O
over	IN	O
the	DT	O
phone	NN	O
improves	VBZ	B-REL
symptoms	NNS	O
of	IN	O
chronic	JJ	O
widespread	JJ	O
pain	NN	O

Phone	NN	O
therapy	NN	O
and	CC	O
exercise	NN	O
can	MD	B-REL
ease	VB	I-REL
chronic	JJ	O
pain	NN	O

such	JJ	O
individuals	NNS	O
are	VBP	B-REL
at	IN	I-REL
a	DT	I-REL
significantly	RB	I-REL
increased	VBN	I-REL
risk	NN	I-REL
of	IN	O
azathioprineinduced	JJ	O
profound	JJ	O
neutropenia	NN	O

individuals	NNS	O
with	IN	O
TPMT	NN	O
variant	JJ	O
homozygosity	NN	O
are	VBP	B-REL
at	IN	I-REL
high	JJ	I-REL
risk	NN	I-REL
of	IN	O
severe	JJ	O
neutropenia	NN	O

Genetic-screening	JJ	O
trial	NN	O
could	MD	B-REL
reduce	VB	I-REL
drug	NN	O
side-effects	NNS	O

These	DT	O
models	NNS	O
are	VBP	O
able	JJ	B-REL
to	TO	I-REL
identify	VB	I-REL
reliably	RB	I-REL
those	DT	O
patients	NNS	O
with	IN	O
expected	VBN	O
prognoses	NNS	O
of	IN	O
days	NNS	O
,	,	O
weeks	NNS	O
,	,	O
or	CC	O
months	NNS	O

A	DT	O
combination	NN	O
of	IN	O
clinical	JJ	O
andlaboratory	JJ	O
variables	NNS	O
can	MD	B-REL
reliably	RB	I-REL
predict	VB	I-REL
two	CD	O
week	NN	O
and	CC	O
two	CD	O
month	NN	O
survival	NN	O

New	NNP	O
scoring	VBG	O
system	NN	O
that	WDT	B-REL
can	MD	I-REL
better	RB	I-REL
predict	VB	I-REL
how	WRB	O
long	JJ	O
patients	NNS	O
with	IN	O
advanced	JJ	O
cancer	NN	O
are	VBP	O
likely	JJ	O
to	TO	O
survive	VB	O
than	IN	O
current	JJ	O
prognosis	NN	O
methods	NNS	O

Cancer	NN	O
scoring	VBG	O
to	TO	B-REL
predict	VB	I-REL
how	WRB	O
long	JJ	O
you	PRP	O
may	MD	O
live	VB	O

A	DT	O
scoring	VBG	O
system	NN	O
that	WDT	O
tells	VBZ	B-REL
incurable	JJ	O
cancer	NN	O
sufferers	NNS	O
how	WRB	O
long	RB	O
they	PRP	O
have	VBP	O
left	VBN	O
to	TO	O
live	VB	O

The	DT	O
significant	JJ	O
differences	NNS	B-REL
found	VBN	O

Boredom	NN	O
is	VBZ	O
provoking	VBG	B-REL
as	RB	O
many	JJ	O
as	IN	O
a	DT	O
third	JJ	O
of	IN	O
drivers	NNS	O
to	TO	O
take	VB	O
unnecessary	JJ	O
risks	NNS	O
at	IN	O
the	DT	O
wheel	NN	O

Green	NNP	O
tea	NN	O
could	MD	B-REL
help	VB	I-REL
ward	VB	I-REL
off	RP	I-REL
dementia	NN	O

This	DT	O
study	NN	O
of	IN	O
UK	NNP	O
retail	JJ	O
milk	NN	O
identified	VBD	O
highly	RB	B-REL
significant	JJ	I-REL
variations	NNS	O
in	IN	O
fat	JJ	O
composition	NN	O

Organic	NNP	O
supermarket	NN	O
milk	NN	O
showed	VBD	O
higher	JJR	B-REL
levels	NNS	I-REL
of	IN	O
nutritionally	RB	O
beneficial	JJ	O
fatty	JJ	O
acids	NNS	O
compared	VBN	O
with	IN	O
`	``	O
ordinary	JJ	O
'	''	O
milk	NN	O

DC	NN	O
deficiency	NN	O
is	VBZ	O
an	DT	O
integral	JJ	B-REL
part	NN	I-REL
of	IN	O
the	DT	O
recently	RB	O
described	VBN	O
syndrome	NN	O
of	IN	O
autosomal	JJ	O
and	CC	O
sporadic	JJ	O
monocytopenia	NN	O
of	IN	O
.	.	O

of	IN	O
monocytopenia	NNP	O
,	,	O
B	NN	O
and	CC	O
NK	NN	O
lymphoid	JJ	O
deficiency	NN	O
additionally	RB	B-REL
includes	VBZ	I-REL
the	DT	O
near	JJ	O
absence	NN	O
of	IN	O
dendritic	JJ	O
cells	NNS	O

researchers	NNS	O
are	VBP	O
the	DT	O
first	JJ	O
in	IN	O
the	DT	O
world	NN	O
to	TO	O
identify	VB	O
the	DT	O
rare	JJ	O
syndrome	NN	O
,	,	O
which	WDT	O
devastates	VBZ	B-REL
the	DT	O
immune	JJ	O
system	NN	O

We	PRP	O
found	VBD	O
that	IN	O
Japanese	JJ	O
monolinguals	NNS	O
show	VBP	O
categorical	JJ	B-REL
perception	NN	I-REL
at	IN	O
the	DT	O
ao/mizuiro	NN	O
boundary	NN	O
whereas	IN	O
English	NNP	O
speakers	NNS	O
do	VBP	O
not	RB	O
.	.	O

Results	NNS	O
showed	VBD	O
that	IN	O
those	DT	O
bilinguals	NNS	O
who	WP	O
used	VBD	O
English	NNP	O
more	RBR	B-REL
frequently	RB	I-REL
distinguished	VBN	I-REL
blue	JJ	I-REL
and	CC	I-REL
light	JJ	I-REL
blue	JJ	O
stimulus	NN	B-REL
pairs	NNS	I-REL
less	RBR	I-REL
well	RB	I-REL
than	IN	O
those	DT	O
who	WP	O
used	VBD	O
Japanese	NNP	O
more	RBR	O
frequently	RB	O
.	.	O

Learning	VBG	O
a	DT	O
foreign	JJ	O
language	NN	O
literally	RB	O
changes	VBZ	B-REL
the	DT	I-REL
way	NN	I-REL
we	PRP	O
see	VBP	O
the	DT	O
world	NN	O

Obese	JJ	O
women	NNS	O
were	VBD	O
at	IN	O
significantly	RB	B-REL
increased	VBN	I-REL
risks	NNS	I-REL
of	IN	O
both	DT	O
fetal	JJ	O
death	NN	O
-LSB-	-LRB-	O
aOR	NN	O
2.32	CD	O
-LRB-	-LRB-	O
95	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
:	:	O
1.64-3	CD	O
.28	CD	O
-RRB-	-RRB-	O
,	,	O
P	NN	O
<	JJR	O
0.001	CD	O
-RSB-	-RRB-	O
and	CC	O
infant	NN	O
death	NN	O

this	DT	O
study	NN	O
found	VBD	O
that	IN	O
the	DT	O
odds	NNS	B-REL
of	IN	I-REL
fetal	JJ	I-REL
death	NN	I-REL
and	CC	I-REL
infant	NN	I-REL
death	NN	O
were	VBD	B-REL
two	CD	I-REL
to	TO	I-REL
three	CD	I-REL
times	NNS	I-REL
greater	JJR	I-REL
for	IN	O
women	NNS	O
who	WP	O
were	VBD	O
obese	JJ	O
at	IN	O
the	DT	O
start	NN	O
of	IN	O
pregnancy	NN	O
compared	VBN	O
with	IN	O
women	NNS	O
of	IN	O
recommended	VBN	O
BMI	NN	O

Women	NNS	O
who	WP	O
are	VBP	O
obese	JJ	O
during	IN	O
early	JJ	O
pregnancy	NN	O
have	VBP	O
a	DT	O
significantly	RB	B-REL
increased	VBN	I-REL
risk	NN	I-REL
of	IN	O
their	PRP$	O
baby	NN	O
dying	VBG	O
before	RB	O
,	,	O
during	IN	O
or	CC	O
up	IN	O
to	TO	O
one	CD	O
year	NN	O
after	IN	O
birth	NN	O

type	NN	O
2	CD	O
diabetes	NN	O
can	MD	B-REL
be	VB	I-REL
reversed	VBN	I-REL
by	IN	O
acute	JJ	O
negative	JJ	O
energy	NN	O
balance	NN	O
alone	RB	O
...	:	O

The	DT	O
abnormalities	NNS	O
underlying	VBG	O
type	NN	O
2	CD	O
diabetes	NNS	O
are	VBP	B-REL
reversible	JJ	I-REL
by	IN	I-REL
reducing	VBG	O
dietary	JJ	O
energy	NN	O
intake	NN	O
.	.	O

Diet	NNP	O
reverses	VBZ	B-REL
Type	NN	O
2	CD	O
Diabetes	NNP	O
.	.	O

diabetes	NN	O
...	:	O
could	MD	B-REL
be	VB	I-REL
wiped	VBN	I-REL
out	RP	I-REL
by	IN	O
cutting	VBG	O
calories	NNS	O
severely	RB	O
for	IN	O
just	RB	O
two	CD	O
months	NNS	O
.	.	O

Ditching	VBG	O
calories	NNS	O
`	``	O
reverses	VBZ	B-REL
diabetes	NNS	O
'	POS	O
.	.	O

A	DT	O
special	JJ	O
600	CD	O
calories-a-day	JJ	O
eating	VBG	O
plan	NN	O
cuts	NNS	B-REL
fat	JJ	O
in	IN	O
the	DT	O
pancreas	NN	O
and	CC	O
prompts	VBZ	O
insulin	NN	O
cells	NNS	O
to	TO	O
wake	VB	O
up	RP	O
.	.	O

EATING	VBG	O
an	DT	O
ultra	NN	O
low-calorie	JJ	O
diet	NN	O
can	MD	B-REL
cure	VB	I-REL
Type	NN	O
2	CD	O
diabetes	NN	O
in	IN	O
just	RB	O
eight	CD	O
weeks	NNS	O
.	.	O

an	DT	O
eight-week	JJ	O
diet	NN	O
could	MD	B-REL
prompt	VB	I-REL
the	DT	O
body	NN	O
to	TO	O
produce	VB	O
its	PRP$	O
own	JJ	O
insulin	NN	O
.	.	O

type	NN	O
2	CD	O
diabetes	NN	O
...	:	O
have	VBP	B-REL
been	VBN	I-REL
cured	VBN	I-REL
...	:	O
by	IN	O
keeping	VBG	O
to	TO	O
an	DT	O
extreme	JJ	O
,	,	O
low-calorie	JJ	O
,	,	O
diet	NN	O
for	IN	O
two	CD	O
months	NNS	O
.	.	O

Adhering	VBG	O
to	TO	O
a	DT	O
strict	JJ	O
600	CD	O
calories	NNS	O
a	DT	O
day	NN	O
causes	VBZ	B-REL
fat	JJ	O
levels	NNS	O
in	IN	O
the	DT	O
pancreas	NN	O
to	TO	O
drop	VB	O
rapidly	RB	O
.	.	O

by	IN	O
following	VBG	O
the	DT	O
eight-week	JJ	O
plan	NN	O
the	DT	O
body	NN	O
can	MD	B-REL
produce	VB	I-REL
its	PRP$	O
own	JJ	O
insulin	NN	O
.	.	O

Strict	JJ	O
diet	NN	O
can	MD	B-REL
reverse	VB	I-REL
diabetes	NN	O
.	.	O

...	:	O
targeted	VBN	O
kinase	NN	O
inhibition	NN	O
to	TO	B-REL
inactivate	VB	I-REL
BRCA1	NN	O
,	,	O
handicap	NN	O
the	DT	O
HR	NN	O
DNA	NN	O
repair	NN	O
machinery	NN	O
...	:	O

...	:	O
reduced	VBN	O
cdk1	NN	O
activity	NN	O
impairs	VBZ	B-REL
BRCA1	NN	O
function	NN	O
and	CC	O
HR	NN	O
repair	NN	O
.	.	O

...	:	O
adds	VBZ	O
weight	NN	O
to	TO	O
a	DT	O
causal	JJ	B-REL
role	NN	I-REL
for	IN	O
somatic	JJ	O
mtDNA	NN	O
mutations	NNS	O
in	IN	O
human	JJ	O
aging	NN	O
...	:	O

...	:	O
progressively	RB	B-REL
accumulate	VBP	I-REL
somatic	JJ	O
mitochondiral	JJ	O
DNA	NN	O
mutations	NNS	O
...	:	O

...	:	O
aging	NN	O
caused	VBN	B-REL
by	IN	I-REL
some	DT	O
HIV	NN	O
drugs	NNS	O
...	:	O

...	:	O
found	VBD	O
that	IN	O
the	DT	O
drugs	NNS	O
...	:	O
damage	NN	B-REL
DNA	NN	O
in	IN	O
the	DT	O
patient	NN	O
's	POS	O
mitochondria	NN	O
...	:	O

Changes	NNS	O
in	IN	O
provision	NN	O
of	IN	O
mental	JJ	O
illness	NN	O
beds	NNS	O
in	IN	O
the	DT	O
NHS	NNP	O
are	VBP	O
associated	VBN	B-REL
with	IN	O
subsequent	JJ	O
changes	NNS	O
in	IN	O
the	DT	O
rate	NN	O
of	IN	O
involuntary	JJ	O
admission	NN	O

The	DT	O
annual	JJ	O
reduction	NN	O
in	IN	O
provision	NN	O
of	IN	O
mental	JJ	O
illness	NN	O
beds	NNS	O
was	VBD	O
assocaited	VBN	B-REL
with	IN	O
the	DT	O
rate	NN	O
of	IN	O
involuntary	JJ	O
admissions	NNS	O

Fewer	JJR	O
mental	JJ	O
illness	NN	O
beds	NNS	O
linked	VBN	B-REL
with	IN	O
increase	NN	O
in	IN	O
involuntary	JJ	O
hospital	NN	O
detentions	NNS	O

The	DT	O
number	NN	O
of	IN	O
people	NNS	O
admitted	VBN	O
to	TO	O
psychiatric	JJ	O
hospitals	NNS	O
against	IN	O
their	PRP$	O
will	MD	O
has	VBZ	O
increase	NN	O
by	IN	O
more	JJR	O
than	IN	O
60	CD	O
per	IN	O
cent	NN	O
in	IN	O
the	DT	O
past	JJ	O
two	CD	O
decades	NNS	O
,	,	O
a	DT	O
rise	NN	O
closely	RB	B-REL
linked	VBN	I-REL
to	TO	O
the	DT	O
overall	JJ	O
reduction	NN	O
in	IN	O
hospital	NN	O
beds	NNS	O

The	DT	O
probability	NN	B-REL
of	IN	O
cell	NN	O
death	NN	O
pathways	NNS	O
being	VBG	O
activated	VBN	O
increases	NNS	O

The	DT	O
probability	NN	B-REL
of	IN	O
cell	NN	O
death	NN	O
pathways	NNS	O
being	VBG	O
activated	VBN	O
increases	NNS	O

all	DT	O
pre-specified	JJ	O
secondary	JJ	O
visual	JJ	O
acuity	NN	O
end-points	NNS	O
,	,	O
subgroup	NN	O
,	,	O
and	CC	O
responder	NN	O
analyses	NNS	O
pointed	VBD	B-REL
towards	IN	I-REL
a	DT	I-REL
beneficial	JJ	I-REL
effect	NN	I-REL
for	IN	I-REL
idebenone	NN	O

all	DT	O
secondary	JJ	O
end-points	NNS	O
were	VBD	B-REL
significantly	RB	I-REL
different	JJ	I-REL
between	IN	O
the	DT	O
idebenone	NN	O
and	CC	O
placebo	NN	O
groups	NNS	O

idebenone	NN	O
-LRB-	-LRB-	O
Catena	NNP	O
-LRB-	-LRB-	O
r	NN	O
-RRB-	-RRB-	O
-RRB-	-RRB-	O
improved	VBD	B-REL
the	DT	O
vision	NN	O
and	CC	O
perception	NN	O
of	IN	O
colour	NN	O
in	IN	O
patients	NNS	O
with	IN	O
Leber	NNP	O
's	POS	O
Hereditary	JJ	O
Optic	NNP	O
Neuropathy	NNP	O
-LRB-	-LRB-	O
LHON	NNP	O
-RRB-	-RRB-	O

A	DT	O
new	JJ	O
drug	NN	O
has	VBZ	O
reversed	VBN	B-REL
sight	NN	O
loss	NN	O
in	IN	O
sufferers	NNS	O
of	IN	O
an	DT	O
eye	NN	O
condition	NN	O
passed	VBD	O
down	RP	O
through	IN	O
families	NNS	O

Aspirin	NN	O
reduced	VBD	B-REL
incidence	NN	I-REL
of	IN	O
colorectal	JJ	O
cancer	NN	O

600	CD	O
mg	NN	O
apsirin	NN	O
per	IN	O
day	NN	O
for	IN	O
a	DT	O
mean	NN	O
of	IN	O
25	CD	O
months	NNS	O
substantially	RB	B-REL
reduced	VBD	I-REL
cancer	NN	O
incidence	NN	O

Asprin	NNP	O
cuts	VBZ	B-REL
cancer	NN	O
rates	NNS	O
in	IN	O
people	NNS	O
with	IN	O
hereditary	JJ	O
risk	NN	O
by	IN	O
more	JJR	O
than	IN	O
half	NN	O

Aspirin	NN	O
every	DT	O
day	NN	O
can	MD	B-REL
cut	VB	I-REL
cancer	NN	O
risk	NN	O

Two	CD	O
aspirins	NNS	O
daily	RB	O
will	MD	B-REL
block	VB	I-REL
cancer	NN	O

Taking	VBG	O
aspirin	NN	O
every	DT	O
day	NN	O
can	MD	B-REL
cut	VB	I-REL
the	DT	O
risk	NN	O
of	IN	O
colon	NN	O
cancer	NN	O

Aspirin	NN	O
slashes	NNS	B-REL
risk	NN	I-REL
of	IN	O
cancer	NN	O

Aspirin	NN	O
can	MD	B-REL
cut	VB	I-REL
bowel	NN	O
cancer	NN	O
risk	NN	O
by	IN	O
half	NN	O

Two	CD	O
aspirins	NNS	O
a	DT	O
day	NN	O
could	MD	B-REL
halve	VB	I-REL
risk	NN	I-REL
of	IN	O
developing	VBG	O
cancer	NN	O

Aspirin	NN	O
cuts	NNS	B-REL
bowel	NN	O
cancer	NN	O
risk	NN	O
by	IN	O
up	RB	O
to	TO	O
two-thirds	NNS	O

Aspirin	NN	O
blocks	VBZ	B-REL
bowler	NN	O
cancer	NN	O

Aspirin	NN	O
slashes	NNS	B-REL
hereditary	JJ	O
cancer	NN	O
risk	NN	O

Aspirin	NN	O
cuts	NNS	B-REL
hereditary	JJ	O
cancer	NN	O
risk	NN	O
,	,	O
study	NN	O
shows	NNS	O

ZFNs	NNS	O
provide	VBP	O
a	DT	B-REL
highly	RB	I-REL
efficient	JJ	I-REL
tool	NN	I-REL
for	IN	I-REL
the	DT	I-REL
deletion	NN	I-REL
of	IN	O
specific	JJ	O
alleles	NNS	O
in	IN	O
KSCs	NNS	O

We	PRP	O
achieved	VBD	O
high	JJ	B-REL
gene	NN	I-REL
disruption	NN	I-REL
efficiencies	NNS	I-REL
with	IN	O
up	RB	O
to	TO	O
18	CD	O
%	NN	O
eGFPnegative	JJ	O
KSCs	NNS	O

5-HT2B	NN	O
negatively	RB	B-REL
influences	VBZ	I-REL
hepatocyte	NN	O
proliferation	NN	O

Antagonism	NN	O
of	IN	O
5-HT2B	NN	O
attenuated	VBD	B-REL
fibrogenesis	NN	O

serotonin	NN	O
receptors	NNS	O
which	WDT	O
can	MD	O
be	VB	O
targeted	VBN	O
with	IN	O
drugs	NNS	O
to	TO	O
enhance	VB	B-REL
the	DT	O
natural	JJ	O
healing	NN	O
properties	NNS	O
of	IN	O
the	DT	O
liver	NN	O

...	:	O
This	DT	O
article	NN	O
found	VBD	O
that	IN	O
time	NN	B-REL
constant	JJ	I-REL
factors	NNS	I-REL
explain	VBP	I-REL
some	DT	I-REL
of	IN	I-REL
the	DT	I-REL
overall	JJ	I-REL
correlation	NN	I-REL
in	IN	O
BMI	NNP	O
for	IN	O
both	DT	O
cohorts	NNS	O
of	IN	O
siblings	NNS	O
...	:	O

...	:	O
the	DT	B-REL
findings	NNS	O
indicate	VBP	O
that	IN	O
time	NN	O
constant	JJ	O
factors	NNS	O
explain	VBP	B-REL
some	DT	I-REL
of	IN	I-REL
the	DT	O
overall	JJ	B-REL
correlation	NN	I-REL
in	IN	O
sibling	NN	O
BMI	NN	O
for	IN	O
both	DT	O
cohorts	NNS	O
of	IN	O
siblings	NNS	O
...	:	O

...	:	O
individual	NN	O
's	POS	O
social	JJ	O
norms	NNS	O
in	IN	O
terms	NNS	O
of	IN	O
what	WP	O
they	PRP	O
consider	VBP	O
acceptable	JJ	O
weight	NN	O
are	VBP	B-REL
formed	VBN	I-REL
during	IN	I-REL
childhood	NN	O
...	:	O

Reported	VBN	O
flooding	NN	O
experiences	NNS	O
had	VBD	O
a	DT	B-REL
significant	JJ	I-REL
relationship	NN	I-REL
with	IN	I-REL
perceptions	NNS	O
relating	VBG	O
to	TO	O
climate	NN	O
change	NN	O

those	DT	O
who	WP	O
report	VBP	O
experience	NN	O
of	IN	O
flooding	NN	O
express	VBP	B-REL
more	JJR	I-REL
concern	NN	I-REL
over	IN	I-REL
climate	NN	O
change	NN	O

Direct	JJ	O
experience	NN	O
of	IN	O
extreme	JJ	O
weather	NN	O
events	NNS	O
increases	VBZ	B-REL
concern	NN	O
about	IN	O
climate	NN	O
change	NN	O

In	IN	O
children	NNS	O
with	IN	O
ADHD	NN	O
,	,	O
attenuated	VBD	B-REL
DMN	NNP	I-REL
deactivation	NN	I-REL
during	IN	O
an	DT	O
inhibitory	JJ	O
control	NN	O
task	NN	O
can	MD	O
be	VB	O
normalised	JJ	O
either	CC	O
by	IN	O
task-related	JJ	O
motivational	JJ	O
incentives	NNS	O
or	CC	O
by	IN	O
methylphenidate	NN	O

children	NNS	O
with	IN	O
ADHD	NN	O
exhibit	VBP	B-REL
a	DT	I-REL
raised	VBN	I-REL
motivational	JJ	I-REL
threshold	NN	I-REL
at	IN	O
which	WDT	O
taskrelevant	JJ	O
stimuli	NNS	O
become	VB	O
sufficiently	RB	O
salient	JJ	O
to	TO	O
deactivate	VB	O
the	DT	O
DMN	NNP	O

Faulty	NNP	O
`	``	O
off-switch	NN	O
'	''	O
stops	VBZ	B-REL
children	NNS	O
with	IN	O
ADHD	NN	O
from	IN	O
concentrating	VBG	O

Children	NNS	O
with	IN	O
hyperactivity	NN	O
disorder	NN	O
have	VBP	B-REL
a	DT	I-REL
faulty	JJ	I-REL
`	``	O
off-switch	NN	O
'	''	B-REL
when	WRB	I-REL
it	PRP	I-REL
comes	VBZ	O
to	TO	O
their	PRP$	O
minds	NNS	O
wandering	VBG	O

CHILDREN	NNS	O
with	IN	O
attention	NN	O
deficit	NN	O
disorder	NN	O
have	VBP	B-REL
brains	NNS	I-REL
that	WDT	I-REL
can	MD	I-REL
not	RB	I-REL
stop	VB	O
daydreaming	VBG	O

Children	NNS	O
with	IN	O
hyperactivity	NN	O
disorder	NN	O
have	VBP	B-REL
a	DT	I-REL
faulty	JJ	I-REL
``	``	O
off-switch	NN	O
''	''	O
when	WRB	B-REL
it	PRP	I-REL
comes	VBZ	O
to	TO	O
their	PRP$	O
minds	NNS	O
wandering	VBG	O

Study	NNP	O
1	CD	O
established	VBD	O
a	DT	O
similar	JJ	O
influence	NN	B-REL
of	IN	I-REL
increased	VBN	O
skin	NN	O
L	NN	O
*	NN	O
and	CC	O
b	NN	O
*	SYM	O
on	IN	O
perceived	VBN	O
health	NN	O

Together	RB	O
our	PRP$	O
studies	NNS	O
link	VBP	B-REL
skin	NN	O
carotenoid	NN	O
coloration	NN	O
to	TO	O
both	DT	O
perceived	VBN	O
health	NN	O
and	CC	O
healthy	JJ	O
diet	NN	O

eating	VBG	O
vegetables	NNS	O
gives	VBZ	B-REL
you	PRP	O
a	DT	O
healthy	JJ	O
tan	NN	O

Scientists	NNS	O
prove	VBP	O
that	IN	O
your	PRP$	O
five	CD	O
a	DT	O
day	NN	O
make	VB	B-REL
you	PRP	O
more	RBR	O
attractive	JJ	O

EATING	VBG	O
fruit	NN	O
and	CC	O
veg	NN	O
can	MD	B-REL
give	VB	I-REL
your	PRP$	O
skin	NN	O
a	DT	O
more	RBR	O
attractive	JJ	O
glow	NN	O
than	IN	O
sunbathing	VBG	O

Reprogramming	VBG	O
with	IN	O
oocyte	NN	O
molecules	NNS	O
which	WDT	O
does	VBZ	O
not	RB	O
require	VB	O
DNA	NN	O
replication	NN	O
,	,	O
can	MD	B-REL
directly	RB	I-REL
remodel	VB	I-REL
cancer	NN	O
cell	NN	O
chromatin	NN	O
and	CC	O
induce	VB	O
re-expression	NN	O
of	IN	O
silenced	VBN	O
tumour	NN	O
suppressor	NN	O
genes	NNS	O
after	IN	O
only	RB	O
6	CD	O
hours	NNS	O
of	IN	O
treatment	NN	O
change	NN	O
...	:	O

axolotl	NN	O
oocyte	NN	O
extracts	NNS	O
possess	VBP	O
superior	JJ	O
reprogramming	NN	O
ability	NN	O
,	,	O
which	WDT	O
reverses	VBZ	B-REL
epigenetic	JJ	O
silencing	NN	O
of	IN	O
tumour	NN	O
suppressor	NN	O
genes	NNS	O
and	CC	O
tumorigenicity	NN	O
of	IN	O
breast	NN	O
cancer	NN	O
cells	NNS	O

Scientists	NNS	O
at	IN	O
The	DT	O
University	NNP	O
of	IN	O
Nottingham	NNP	O
have	VBP	B-REL
brought	VBN	I-REL
cancer	NN	O
cells	NNS	O
back	RB	O
under	IN	O
normal	JJ	O
control	NN	O
--	:	O
by	IN	O
reactivating	VBG	O
their	PRP$	O
cancer	NN	O
suppressor	NN	O
genes	NNS	O

A	DT	O
new	JJ	O
treatment	NN	O
for	IN	O
cancer	NN	O
that	WDT	O
renders	VBZ	B-REL
malignant	JJ	O
tumours	NNS	O
``	``	O
dormant	JJ	O
''	''	O
has	VBZ	O
been	VBN	O
developed	VBN	O
by	IN	O
scientist	NN	O

explicit	JJ	O
financial	JJ	O
incentives	NNS	O
did	VBD	B-REL
not	RB	I-REL
improve	VB	I-REL
the	DT	O
quality	NN	O
of	IN	O
care	NN	O
and	CC	O
clinical	JJ	O
outcomes	NNS	O
for	IN	O
patients	NNS	O
with	IN	O
hypertension	NN	O

Pay	VB	O
for	IN	O
performance	NN	O
had	VBD	B-REL
no	DT	I-REL
discernible	JJ	I-REL
effects	NNS	I-REL
on	IN	O
processes	NNS	O
of	IN	O
care	NN	O
or	CC	O
on	IN	O
hypertension	NN	O
related	JJ	O
clinical	JJ	O
outcomes	NNS	O

Pay	VB	O
for	IN	O
performance	NN	O
targets	NNS	O
set	VBN	O
for	IN	O
GPs	NNS	O
in	IN	O
the	DT	O
UK	NNP	O
are	VBP	B-REL
failing	VBG	I-REL
to	TO	I-REL
improve	VB	I-REL
the	DT	O
health	NN	O
of	IN	O
patients	NNS	O
with	IN	O
high	JJ	O
blood	NN	O
pressure	NN	O

these	DT	O
schemes	NNS	O
are	VBP	B-REL
associated	VBN	I-REL
with	IN	I-REL
a	DT	O
higher	JJR	O
rate	NN	O
of	IN	O
diagnoses	NNS	O
of	IN	O
STIs	NNS	O
amongst	IN	O
teenagers	NNS	O

pharmacy	NN	O
EBC	NN	O
schemes	NNS	O
are	VBP	B-REL
associated	VBN	I-REL
with	IN	I-REL
higher	JJR	O
teenage	JJ	O
STI	NN	O
rates	NNS	O

Morning	NN	O
after	IN	O
pill	NN	O
linked	VBN	B-REL
to	TO	I-REL
increase	VB	O
in	IN	O
STIs	NNS	O

THE	DT	O
drive	NN	O
to	TO	B-REL
give	VB	O
free	JJ	O
morning-after	NN	O
pills	NNS	O
to	TO	O
teenage	JJ	O
girls	NNS	O
has	VBZ	B-REL
failed	VBN	I-REL
to	TO	O
cut	VB	B-REL
underage	JJ	O
pregnancies	NNS	O

A	DT	O
GOVERNMENT	NN	O
scheme	NN	O
to	TO	B-REL
give	VB	O
teenagers	NNS	O
the	DT	O
morning-after	JJ	O
pill	NN	O
free	JJ	O
of	IN	O
charge	NN	O
at	IN	O
pharmacies	NNS	O
in	IN	O
an	DT	O
attempt	NN	O
to	TO	O
cut	VB	O
down	RP	O
on	IN	O
unwanted	JJ	O
pregnancies	NNS	O
has	VBZ	B-REL
led	VBN	I-REL
to	TO	O
a	DT	O
rise	NN	O
in	IN	O
sexually	RB	O
transmitted	JJ	O
diseases	NNS	O

AN	DT	O
official	JJ	O
scheme	NN	O
to	TO	O
give	VB	O
the	DT	O
morning-after	JJ	O
pill	NN	O
free	JJ	O
to	TO	O
teenagers	NNS	O
at	IN	O
chemists	NNS	O
has	VBZ	O
backfired	VBN	O
by	IN	O
increasing	VBG	B-REL
the	DT	O
rates	NNS	O
of	IN	O
sexually	RB	O
transmitted	JJ	O
diseases	NNS	O

there	EX	O
are	VBP	O
further	JJ	O
adverse	JJ	B-REL
effects	NNS	I-REL
of	IN	O
maternal	JJ	O
secondhand	JJ	O
smoke	NN	O
exposure	NN	O
during	IN	O
pregnancy	NN	O
on	IN	O
the	DT	O
health	NN	O
of	IN	O
the	DT	O
fetus	NN	O
through	IN	O
increased	VBN	O
risks	NNS	O
of	IN	O
congenital	JJ	O
malformations	NNS	O
,	,	O
stillbirths	NNS	O
,	,	O
and	CC	O
possibly	RB	O
other	JJ	O
adverse	JJ	O
fetal	JJ	O
outcomes	NNS	O

Pregnant	JJ	O
women	NNS	O
who	WP	O
are	VBP	O
exposed	VBN	O
to	TO	B-REL
secondhand	JJ	O
smoke	NN	O
are	VBP	O
estimated	VBN	O
to	TO	O
be	VB	O
23	CD	B-REL
%	NN	I-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	O
experience	VB	B-REL
stillbirth	NN	O
and	CC	O
13	CD	O
%	NN	O
more	RBR	O
likely	JJ	O
give	VBP	O
birth	NN	O
to	TO	O
a	DT	O
child	NN	O
with	IN	O
a	DT	O
congenital	JJ	O
malformation	NN	O

Pregnant	JJ	O
non-smokers	NNS	O
who	WP	O
breathe	VBP	O
in	IN	O
the	DT	O
second-hand	JJ	O
smoke	NN	O
of	IN	O
other	JJ	O
people	NNS	O
are	VBP	O
at	IN	O
an	DT	O
increased	VBN	B-REL
risk	NN	I-REL
of	IN	O
delivering	VBG	O
stillborn	JJ	O
babies	NNS	O
or	CC	O
babies	NNS	O
with	IN	O
defects	NNS	O

that	IN	O
pregnant	JJ	O
women	NNS	O
exposed	VBN	O
to	TO	O
smoke	VB	O
at	IN	O
work	NN	O
or	CC	O
home	NN	O
increased	VBD	B-REL
their	PRP$	I-REL
risk	NN	I-REL
of	IN	O
stillbirth	NN	O
by	IN	O
23	CD	O
%	NN	O
and	CC	O
of	IN	O
having	VBG	O
a	DT	O
baby	NN	O
with	IN	O
defects	NNS	O
by	IN	O
13	CD	O
%	NN	O

Women	NNS	O
exposed	VBN	O
to	TO	B-REL
second-hand	JJ	O
smoke	NN	O
while	IN	O
pregnant	JJ	O
are	VBP	B-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	O
experience	VB	B-REL
a	DT	O
stillbirth	NN	O
or	CC	O
have	VB	O
babies	NNS	O
with	IN	O
birth	NN	O
defects	NNS	O

enhanced	VBN	O
cognitive	JJ	O
control	NN	O
of	IN	O
motor	NN	O
output	NN	O
in	IN	O
TS	NN	O
is	VBZ	B-REL
accompanied	VBN	I-REL
by	IN	I-REL
adaptive	JJ	O
functional	JJ	O
and	CC	O
structural	JJ	O
changes	NNS	O
in	IN	O
the	DT	O
prefrontal	JJ	O
cortex	NN	O
motor	NN	O
output	NN	O
in	IN	O
TS	NN	O
is	VBZ	O
accompanied	VBN	O
by	IN	O
adaptive	JJ	O
functional	JJ	O
and	CC	O
structural	JJ	O
changes	NNS	O
in	IN	O
the	DT	O
prefrontal	JJ	O
cortex	NN	O
...	:	O

These	DT	O
results	NNS	O
provide	VBP	O
evidence	NN	O
for	IN	O
compensatory	JJ	O
brain	NN	O
reorganization	NN	O
that	WDT	O
may	MD	B-REL
underlie	VB	I-REL
the	DT	O
increased	VBN	O
self-regulation	NN	O
mechanisms	NNS	O

the	DT	O
brains	NNS	O
of	IN	O
children	NNS	O
with	IN	O
Tourette	NN	O
syndrome	NN	O
-LRB-	-LRB-	O
TS	NN	O
-RRB-	-RRB-	O
develop	VBP	B-REL
in	IN	O
a	DT	O
unique	JJ	O
way	NN	O

This	DT	O
study	NN	O
found	VBD	O
no	DT	B-REL
benefit	NN	I-REL
of	IN	O
using	VBG	O
an	DT	O
ion-exchange	JJ	O
water	NN	O
softener	NN	O
in	IN	O
addition	NN	O
to	TO	O
usual	JJ	O
care	NN	O
in	IN	O
children	NNS	O
with	IN	O
eczema	NN	O

Water	NN	O
softeners	NNS	O
provided	VBD	B-REL
no	DT	I-REL
additional	JJ	I-REL
benefit	NN	I-REL
to	TO	O
usual	JJ	O
care	NN	O

installing	VBG	O
a	DT	O
water	NN	O
softener	NN	O
for	IN	O
three	CD	O
months	NNS	O
brings	VBZ	B-REL
no	DT	I-REL
additional	JJ	I-REL
relief	NN	I-REL
for	IN	O
eczema	NN	O
sufferers	NNS	O

This	DT	O
can	MD	B-REL
cause	VB	I-REL
replication	NN	O
fork	NN	O
stalling	VBG	O
and/or	CC	O
collapse	NN	O
that	WDT	O
leads	VBZ	O
to	TO	O
the	DT	O
intervention	NN	O
by	IN	O
the	DT	O
replication	NN	O
restart	VB	O
machinery	NN	O

co-directional	JJ	O
transcription	NN	O
can	MD	B-REL
disrupt	VB	I-REL
replication	NN	O
leading	VBG	O
to	TO	O
the	DT	O
involvement	NN	O
of	IN	O
replication	NN	O
restart	VBP	O
proteins	NNS	O

Collisions	NNS	O
of	IN	O
protein	NN	O
machines	NNS	O
cause	VBP	B-REL
DNA	NN	O
replication	NN	O
derailment	NN	O

putative	JJ	O
receptors	NNS	O
on	IN	O
antigen-presenting	JJ	O
cells	NNS	O
that	WDT	O
play	VBP	B-REL
a	DT	I-REL
central	JJ	I-REL
role	NN	I-REL
in	IN	O
allergen	NN	O
uptake	NN	O
and	CC	O
downstream	JJ	O
events	NNS	O
leading	VBG	O
to	TO	O
IgE	NN	O
production	NN	O

MR	NN	O
is	VBZ	B-REL
likely	JJ	I-REL
to	TO	I-REL
play	VB	I-REL
a	DT	I-REL
pivotal	JJ	I-REL
role	NN	I-REL
in	IN	O
allergic	JJ	O
sensitization	NN	O
to	TO	O
airborne	JJ	O
allergens	NNS	O
in	FW	O
vivo	FW	O

identified	VBN	O
a	DT	B-REL
cell	NN	O
component	NN	O
which	WDT	O
plays	VBZ	B-REL
a	DT	O
key	JJ	B-REL
role	NN	I-REL
in	IN	I-REL
triggering	VBG	I-REL
allergic	JJ	O
responses	NNS	O
to	TO	O
cat	NN	O
dander	NN	O

variants	NNS	O
at	IN	O
ABCA7	NN	O
and	CC	O
the	DT	O
MS4A	NN	O
gene	NN	O
cluster	NN	O
associated	VBN	B-REL
with	IN	I-REL
susceptibility	NN	O
to	TO	O
Alzheimer	NNP	O
's	POS	O
disease	NN	O

association	NN	B-REL
for	IN	O
three	CD	O
loci	NNS	O
reported	VBN	O
by	IN	O
the	DT	O
ADGC	NN	O

a	DT	B-REL
total	NN	O
of	IN	O
ten	CD	O
genes	NNS	O
are	VBP	O
now	RB	O
known	VBN	O
to	TO	B-REL
play	VB	I-REL
a	DT	O
role	NN	B-REL
in	IN	O
late-onset	JJ	O
Alzheimer	NN	O
's	POS	O

Genetic	JJ	O
study	NN	O
uncovers	VBZ	O
causes	NNS	B-REL
of	IN	O
Alzheimer	NN	O
's	POS	O
Disease	NN	O

FIVE	CD	O
genes	NNS	O
found	VBN	O
to	TO	O
increase	VB	B-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
Alzheimer	NN	O
's	POS	O

A	DT	O
set	NN	O
of	IN	O
five	CD	O
genes	NNS	O
that	WDT	O
affect	VBP	B-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
developing	VBG	O
Alzheimer	NN	O
's	POS	O
disease	NN	O

five	CD	O
gene	NN	O
variants	NNS	O
that	WDT	O
raise	VBP	B-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
Alzheimer	NN	O
's	POS	O
disease	NN	O

A	DT	O
new	JJ	O
set	NN	O
of	IN	O
genes	NNS	O
linked	VBN	B-REL
to	TO	I-REL
Alzheimer	NNP	O
's	POS	O
has	VBZ	O
been	VBN	O
discovered	VBN	O

handful	NN	O
of	IN	O
genes	NNS	O
that	WDT	O
are	VBP	O
strongly	RB	B-REL
implicated	VBN	I-REL
in	IN	O
raising	VBG	O
a	DT	O
person	NN	O
's	POS	O
risk	NN	O
of	IN	O
developing	VBG	O
the	DT	O
brain	NN	O
disorder	NN	O
in	IN	O
later	JJ	O
life	NN	O

Five	CD	O
more	JJR	O
genes	NNS	O
which	WDT	O
increase	VBP	B-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
developing	VBG	O
Alzheimer	NN	O
's	POS	O
disease	NN	O

Scientists	NNS	O
looking	VBG	O
for	IN	O
the	DT	O
genetic	JJ	O
triggers	NNS	B-REL
that	WDT	I-REL
lead	VBP	I-REL
to	TO	O
Alzheimer	NNP	O
's	POS	O
have	VBP	O
identified	VBN	O
five	CD	O
more	JJR	O

...	:	O
substance	NN	O
abuse	NN	O
has	VBZ	O
been	VBN	O
identified	VBN	O
as	IN	O
particularly	RB	B-REL
strongly	RB	I-REL
related	JJ	I-REL
to	TO	O
the	DT	O
recidivism	NN	O
of	IN	O
female	NN	O
...	:	O

...	:	O
Alcohol	NN	O
increases	VBZ	B-REL
the	DT	I-REL
likelihood	NN	I-REL
of	IN	O
violence	NN	O
...	:	O

Female	JJ	O
drink-drivers	NNS	O
are	VBP	B-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	O
be	VB	O
older	JJR	O
,	,	O
better-educated	JJ	O
and	CC	O
divorced	VBN	O
,	,	O
widowed	VBN	O
or	CC	O
separated	VBN	O
,	,	O

...	:	O
drink	NN	O
driving	VBG	O
women	NNS	O
are	VBP	B-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	I-REL
be	VB	I-REL
older	JJR	O
,	,	O
better	RBR	O
educated	VBN	O
and	CC	O
divorced	VBN	O
...	:	O

...	:	O
group-based	JJ	O
interventions	NNS	O
based	VBN	O
upon	IN	O
CBT	NNP	O
principles	NNS	O
were	VBD	B-REL
successful	JJ	I-REL
at	IN	I-REL
improving	VBG	I-REL
the	DT	O
mood	NN	O
of	IN	O
patients	NNS	O
with	IN	O
MS	NN	O
who	WP	O
had	VBD	O
low	JJ	O
mood	NN	O
.	.	O

Patients	NNS	O
receiving	VBG	O
treatment	NN	O
were	VBD	B-REL
less	JJR	I-REL
distressed	JJ	I-REL
and	CC	I-REL
had	VBD	I-REL
less	JJR	O
depression	NN	B-REL
and	CC	O
anxiety	NN	O
.	.	O

Group	NNP	O
therapy	NN	O
helps	VBZ	B-REL
MS	NN	O
sufferers	NNS	O
cope	VBP	O
with	IN	O
depression	NN	O
.	.	O

Such	JJ	O
effects	NNS	B-REL
of	IN	O
R	NN	O
-LRB-	-LRB-	O
-RRB-	-RRB-	O
WIN55,212-2	NN	O
,	,	O
in	IN	O
particular	JJ	O
its	PRP$	O
capacity	NN	O
to	TO	O
induce	VB	O
endogenous	JJ	O
IFN	NN	O
-	:	O

R	NN	O
-LRB-	-LRB-	O
-RRB-	-RRB-	O
WIN55,212-2	NN	O
as	IN	O
a	DT	B-REL
novel	JJ	I-REL
regulator	NN	I-REL
of	IN	I-REL
TLR3	NN	O
signaling	NN	O
to	TO	O
IRF3	NN	O
activation	NN	O
and	CC	O
IFN	NN	O
-	:	O
expression	NN	O

synthetic	JJ	O
chemical	NN	O
compound	NN	O
which	WDT	O
inhibits	VBZ	B-REL
the	DT	O
pro-inflammatory	JJ	O
signals	NNS	O
produced	VBN	O
by	IN	O
the	DT	O
immune	JJ	O
system	NN	O
in	IN	O
MS	NN	O

...	:	O
the	DT	O
observed	VBN	B-REL
effects	NNS	I-REL
were	VBD	I-REL
unique	JJ	I-REL
to	TO	I-REL
the	DT	O
Chinese-English	JJ	O
bilinguals	NNS	O
...	:	O

Chinese-English	JJ	O
bilinguals	NNS	O
responded	VBD	B-REL
to	TO	O
English	NNP	O
target	NN	O
words	NNS	O
...	:	O

bilinguals	NNS	O
'	POS	O
native	JJ	O
language	NN	O
directly	RB	B-REL
influences	VBZ	I-REL
their	PRP$	O
comprehension	NN	O
of	IN	O
their	PRP$	O
second	JJ	O
language	NN	O
.	.	O

This	DT	O
observational	JJ	O
study	NN	O
found	VBD	O
significant	JJ	B-REL
associations	NNS	I-REL
between	IN	O
use	NN	O
of	IN	O
antidepressant	JJ	O
drugs	NNS	O
and	CC	O
several	JJ	O
severe	JJ	O
adverse	JJ	O
outcomes	NNS	O
in	IN	O
people	NNS	O
aged	JJ	O
65	CD	O
and	CC	O
older	JJR	O
with	IN	O
depression	NN	O

SSRIs	NNS	O
and	CC	O
drugs	NNS	O
in	IN	O
the	DT	O
group	NN	O
of	IN	O
other	JJ	O
antidepressants	NNS	O
were	VBD	B-REL
associated	VBN	I-REL
with	IN	I-REL
an	DT	I-REL
increased	VBN	I-REL
risk	NN	I-REL
of	IN	O
several	JJ	O
adverse	JJ	O
outcomes	NNS	O
compared	VBN	O
with	IN	O
tricyclic	JJ	O
antidepressants	NNS	O

New	NNP	O
antidepressants	NNS	O
increase	VBP	B-REL
risks	NNS	I-REL
for	IN	O
eldarly	JJ	O

Prozac	NNP	O
`	``	O
increases	NNS	B-REL
risk	NN	I-REL
of	IN	O
death	NN	O
in	IN	O
over	IN	O
65s	NNS	O
'	POS	O

This	DT	O
region	NN	O
acts	VBZ	B-REL
as	IN	I-REL
a	DT	I-REL
key	JJ	I-REL
controller	NN	I-REL
of	IN	O
mimicry	NN	O
by	IN	O
eye	NN	O
contact	NN	O
and	CC	O
performs	VBZ	O
this	DT	O
function	NN	O
by	IN	O
modulating	VBG	O
sensory	JJ	O
inputs	NNS	O
to	TO	O
action	NN	O
systems	NNS	O

mPFC	NN	O
is	VBZ	B-REL
the	DT	I-REL
originator	NN	I-REL
of	IN	O
the	DT	O
gaze-mimicry	JJ	O
interaction	NN	O
and	CC	O
it	PRP	O
modulates	VBZ	O
sensory	JJ	O
input	NN	O
to	TO	O
the	DT	O
mirror	NN	O
system	NN	O

It	PRP	B-REL
can	MD	I-REL
help	VB	I-REL
identify	VB	I-REL
patients	NNS	O
at	IN	O
high	JJ	O
risk	NN	O
of	IN	O
venous	JJ	O
thromboembolism	NN	O
...	:	O

...	:	O
new	JJ	O
risk	NN	O
prediction	NN	O
tool	NN	O
can	MD	B-REL
identify	VB	I-REL
patients	NNS	O
at	IN	O
high	JJ	O
risk	NN	O
of	IN	O
serious	JJ	O
blood	NN	O
clots	NNS	O
...	:	O

...	:	O
could	MD	B-REL
lower	VB	I-REL
their	PRP$	I-REL
chance	NN	I-REL
off	IN	O
developing	VBG	O
potenitally	RB	O
fatal	JJ	O
bood	NN	O
clots	NNS	O
with	IN	O
an	DT	O
online	JJ	O
test	NN	O
...	:	O

...	:	O
we	PRP	O
found	VBD	O
no	DT	B-REL
protective	JJ	I-REL
effect	NN	I-REL
of	IN	O
breastfeeding	NN	O
and	CC	O
delayed	VBN	O
weaning	VBG	O
on	IN	O
eczema	NN	O
risk	NN	O
...	:	O

...	:	O
although	IN	O
there	EX	O
was	VBD	O
a	DT	B-REL
protective	JJ	I-REL
effect	NN	I-REL
of	IN	O
ever	RB	O
having	VBG	O
been	VBN	O
breastfed	VBN	O
...	:	O

...	:	O
prolonged	JJ	O
breastfeeding	NN	O
does	VBZ	B-REL
not	RB	I-REL
protect	VB	I-REL
against	IN	O
eczema	NN	O
...	:	O

...	:	O
breastfed	VBD	O
babies	NNS	O
are	VBP	B-REL
not	RB	I-REL
protected	VBN	I-REL
against	IN	O
eczema	NN	O
...	:	O

...	:	O
most	RBS	O
importantly	RB	O
,	,	O
we	PRP	O
have	VBP	O
shown	VBN	O
significant	JJ	B-REL
similarity	NN	I-REL
between	IN	O
RSNs	NNS	O
derived	VBN	O
from	IN	O
MEG	NNP	O
and	CC	O
fMRI	NNP	O
data	NNS	O
...	:	O

...	:	O
this	DT	O
method	NN	O
results	VBZ	B-REL
in	IN	I-REL
RSNs	NNS	I-REL
with	IN	O
significant	JJ	O
similarity	NN	O
in	IN	O
their	PRP$	O
spatial	JJ	O
structure	NN	O
...	:	O

...	:	O
a	DT	O
new	JJ	O
technique	NN	O
which	WDT	B-REL
lets	VBZ	I-REL
scientists	NNS	I-REL
`	``	O
see	VBP	O
'	''	B-REL
our	PRP$	O
brain	NN	O
waves	NNS	O
at	IN	O
work	NN	O
...	:	O

we	PRP	O
report	VBP	O
genome-wide	JJ	O
significant	JJ	B-REL
associations	NNS	I-REL

We	PRP	O
identified	VBD	O
16	CD	O
additional	JJ	O
new	JJ	O
loci	NNS	O
for	IN	O
lung	NN	O
function	NN	O
and	CC	O
provided	VBD	O
evidence	NN	O
corrobo	NN	O
-	:	O
rating	NN	O
the	DT	O
association	NN	B-REL
of	IN	O
loci	NNS	O
previously	RB	O
associated	VBN	O
with	IN	O
lung	NN	O
func	NN	O
-	:	O
tion	NN	O

sixteen	CD	O
new	JJ	O
sections	NNS	O
of	IN	O
the	DT	O
genetic	JJ	O
code	NN	O
that	WDT	O
relate	VBP	B-REL
to	TO	I-REL
lung	NN	O
health	NN	O

This	DT	O
can	MD	B-REL
therefore	RB	I-REL
be	VB	I-REL
used	VBN	I-REL
as	IN	I-REL
a	DT	I-REL
prediction	NN	I-REL
model	NN	O
to	TO	O
identify	VB	O
patients	NNS	O
with	IN	O
an	DT	O
existing	VBG	O
but	CC	O
as	RB	O
yet	RB	O
undiagnosed	JJ	O
lung	NN	O
cancer	NN	O

the	DT	O
algorithm	NN	O
is	VBZ	O
successful	JJ	B-REL
in	IN	I-REL
identifying	VBG	I-REL
those	DT	O
suffering	VBG	O
with	IN	O
gastro-oesophageal	JJ	O
cancer	NN	O
and	CC	O
lung	NN	O
cancer	NN	O

...	:	O
this	DT	O
systematic	JJ	O
review	NN	O
has	VBZ	O
found	VBN	O
little	JJ	B-REL
evidence	NN	I-REL
to	TO	I-REL
support	VB	I-REL
the	DT	I-REL
view	NN	I-REL
that	IN	I-REL
childhood	NN	I-REL
obesity	NN	I-REL
is	VBZ	I-REL
an	DT	I-REL
independent	JJ	I-REL
risk	NN	I-REL
factor	NN	I-REL
for	IN	I-REL
adult	JJ	O
blood	NN	O
lipid	NN	O
status	NN	O
,	,	O
insulin	NN	O
levels	NNS	O
,	,	O
metabolic	JJ	O
syndrome	NN	O
or	CC	O
type	NN	O
2	CD	O
diabetes	NN	O
...	:	O

...	:	O
where	WRB	O
adult	JJ	O
BMI	NNP	O
was	VBD	O
adjusted	VBN	O
for	IN	O
,	,	O
the	DT	O
data	NNS	O
showed	VBD	O
a	DT	B-REL
weak	JJ	I-REL
negative	JJ	I-REL
association	NN	I-REL
between	IN	O
childhood	NN	O
BMI	NN	O
and	CC	O
metabolic	JJ	O
variables	NNS	O
...	:	O

...	:	O
a	DT	B-REL
second	JJ	O
systematic	JJ	O
review	NN	O
of	IN	B-REL
research	NN	O
into	IN	O
childhood	NN	O
obesity	NN	O
and	CC	O
metabolic	JJ	O
disease	NN	O
in	IN	O
adult	JJ	O
life	NN	O
has	VBZ	O
shown	VBN	O
there	EX	B-REL
is	VBZ	I-REL
little	JJ	I-REL
evidence	NN	I-REL
of	IN	O
a	DT	O
direct	JJ	B-REL
link	NN	I-REL
...	:	O

The	DT	O
UKBOI	NNP	O
study	NN	O
show	VBP	O
that	IN	O
combining	VBG	O
empirical	JJ	O
data	NNS	O
from	IN	O
injured	JJ	O
individuals	NNS	O
with	IN	O
multiple	JJ	O
sources	NNS	O
of	IN	O
incidence	NN	O
data	NNS	O
produces	VBZ	O
much	RB	B-REL
higher	JJR	I-REL
estimates	NNS	O
of	IN	O
population	NN	O
burden	NN	O
of	IN	O
injuries	NNS	O
than	IN	O
the	DT	O
GBD	NN	O
study	NN	O
methodology	NN	O

The	DT	O
absolute	JJ	O
burden	NN	O
of	IN	O
injury	NN	O
is	VBZ	O
higher	JJR	B-REL
than	IN	I-REL
previously	RB	O
thought	VBN	O

Impact	NN	O
of	IN	O
injuries	NNS	O
in	IN	O
the	DT	O
UK	NNP	O
more	JJR	B-REL
than	IN	I-REL
two	CD	I-REL
and	CC	I-REL
a	DT	I-REL
half	JJ	I-REL
times	NNS	I-REL
higher	JJR	I-REL
than	IN	O
-LSB-	-LRB-	O
previously	RB	O
-RSB-	-RRB-	O
estimated	VBN	O

BCSP	NN	O
in	IN	O
England	NNP	O
is	VBZ	O
on	IN	B-REL
track	NN	I-REL
to	TO	I-REL
match	VB	I-REL
the	DT	I-REL
16	CD	I-REL
%	NN	I-REL
reduction	NN	I-REL
in	IN	O
CRC	NN	O
mortality	NN	O
found	VBN	O
in	IN	O
the	DT	O
randomised	JJ	O
trials	NNS	O
of	IN	O
gFOBt	NN	O
screening	NN	O

there	EX	O
was	VBD	O
the	DT	O
expected	VBN	O
improvement	NN	B-REL
in	IN	O
cancer	NN	O
stage	NN	O
at	IN	O
diagnosis	NN	O

Bowel	NN	O
cancer	NN	O
screening	NN	O
proven	VBN	B-REL
to	TO	I-REL
save	VB	I-REL
lives	NNS	O

A	DT	O
bowel	NN	O
cancer	NN	O
screening	NN	O
programme	NN	O
in	IN	O
England	NNP	O
is	VBZ	B-REL
on	IN	I-REL
course	NN	I-REL
to	TO	I-REL
cut	VB	I-REL
deaths	NNS	O

...	:	O
successful	JJ	O
IgG	NN	O
Fc-fusion	NN	O
platform	NN	O
for	IN	O
the	DT	B-REL
simultaneous	JJ	O
delivery	NN	O
of	IN	O
multiple	JJ	O
Ags	NNS	O
and/or	CC	O
ligands	NNS	O
to	TO	O
the	DT	O
immune	JJ	O
system	NN	O
that	WDT	O
may	MD	B-REL
mimic	VB	I-REL
the	DT	O
`	``	O
depot-effect	NN	O
'	''	O
of	IN	O
ICs	NNS	O
,	,	O
...	:	O

...	:	O
polymeric	JJ	O
Fc-fusions	NNS	O
were	VBD	B-REL
significantly	RB	I-REL
less	JJR	I-REL
immunogenic	JJ	I-REL
than	IN	I-REL
their	PRP$	O
dimeric	JJ	O
or	CC	O
monomeric	JJ	O
counterparts	NNS	O
...	:	O

algorithm	NN	O
that	WDT	O
can	MD	B-REL
be	VB	I-REL
used	VBN	I-REL
to	TO	I-REL
help	VB	I-REL
identify	VB	I-REL
symptomatic	JJ	O
patients	NNS	O
in	IN	O
primary	JJ	O
care	NN	O
at	IN	O
high	JJ	O
risk	NN	O
of	IN	O
having	VBG	O
an	DT	O
existing	VBG	O
,	,	O
but	CC	O
as	RB	O
yet	RB	O
undiagnosed	JJ	O
,	,	O
colorectal	JJ	O
cancer	NN	O

The	DT	O
algorithm	NN	O
...	:	O
could	MD	B-REL
potentially	RB	I-REL
be	VB	I-REL
used	VBN	I-REL
to	TO	I-REL
help	VB	I-REL
identify	VB	I-REL
those	DT	O
at	IN	O
highest	JJS	O
risk	NN	O
of	IN	O
current	JJ	O
colorectal	JJ	O
cancer	NN	O

Simple	JJ	O
test	NN	O
to	TO	O
help	VB	B-REL
diagnose	VB	I-REL
bowel	NN	O
and	CC	O
pancreatic	JJ	O
cancer	NN	O

Providing	VBG	O
education	NN	O
th	DT	O
low	JJ	O
cost/free	NN	O
equipment	NN	O
th	DT	O
fitting	JJ	O
th	DT	O
home	NN	O
inspection	NN	O
had	VBD	B-REL
the	DT	I-REL
highest	JJS	I-REL
probability	NN	I-REL
of	IN	I-REL
increasing	VBG	I-REL
functional	JJ	O
alarms	NNS	O

The	DT	O
intervention	NN	O
containing	VBG	O
all	DT	O
of	IN	O
the	DT	B-REL
aforementioned	JJ	O
components	NNS	O
was	VBD	O
identified	VBN	O
as	IN	O
being	VBG	O
the	DT	O
most	RBS	B-REL
likely	JJ	I-REL
to	TO	I-REL
be	VB	I-REL
the	DT	O
most	RBS	O
effective	JJ	B-REL

A	DT	O
combined	JJ	O
approach	NN	O
of	IN	O
offering	VBG	O
education	NN	O
,	,	O
free	JJ	O
or	CC	O
low-cost	JJ	O
equipment	NN	O
and	CC	O
a	DT	O
home	NN	O
safety	NN	O
inspection	NN	O
is	VBZ	B-REL
likely	JJ	I-REL
to	TO	I-REL
have	VB	I-REL
the	DT	I-REL
most	RBS	I-REL
impact	NN	O

The	DT	O
most	RBS	O
powerful	JJ	O
influence	NN	B-REL
we	PRP	O
have	VBP	O
uncovered	VBN	O
on	IN	O
levels	NNS	O
of	IN	O
obesity	NN	O
is	VBZ	O
insecurity	NN	O

Economic	NNP	O
insecurity	NN	O
,	,	O
measured	VBN	O
in	IN	O
several	JJ	O
different	JJ	O
ways	NNS	O
,	,	O
was	VBD	B-REL
almost	RB	I-REL
twice	RB	I-REL
as	IN	I-REL
powerful	JJ	I-REL

the	DT	O
stress	NN	O
of	IN	O
living	NN	O
in	IN	O
a	DT	O
competitive	JJ	O
social	JJ	O
system	NN	O
without	IN	O
a	DT	O
strong	JJ	O
welfare	NN	O
state	NN	O
could	MD	B-REL
be	VB	I-REL
causing	VBG	I-REL
people	NNS	O
to	TO	O
overeat	VB	O

Money	NNP	O
stresses	VBZ	O
in	IN	O
countries	NNS	O
like	IN	O
the	DT	O
UK	NNP	O
and	CC	O
US	NNP	O
could	MD	B-REL
explain	VB	I-REL
their	PRP$	O
higher	JJR	O
obesity	NN	O
levels	NNS	O

economic	JJ	O
insecurity	NN	O
boosts	VBZ	B-REL
obesity	NN	O

a	DT	O
range	NN	O
of	IN	O
lifehistory	NN	O
trait	NN	O
trade-offs	NNS	O
and	CC	O
variability	NN	O
regimes	NNS	O
that	WDT	O
are	VBP	B-REL
likely	JJ	I-REL
to	TO	I-REL
influence	VB	I-REL
the	DT	O
evolution	NN	O
of	IN	O
parental	JJ	O
care	NN	O
in	IN	O
stochastic	JJ	O
environments	NNS	O

environmental	JJ	O
variability	NN	O
,	,	O
the	DT	O
life-history	JJ	O
traits	NNS	O
affected	VBN	O
by	IN	O
such	JJ	O
variability	NN	O
and	CC	O
the	DT	O
specific	JJ	O
costs	NNS	O
of	IN	O
care	NN	O
interact	VBP	O
to	TO	O
determine	VB	B-REL
whether	IN	O
care	NN	O
will	MD	O
be	VB	O
favoured	VBN	O
in	IN	O
a	DT	O
variable	JJ	O
environment	NN	O
and	CC	O
what	WP	O
levels	NNS	O
of	IN	O
care	NN	O
will	MD	O
be	VB	O
selected	VBN	O

Changes	NNS	O
in	IN	O
the	DT	O
environment	NN	O
that	WDT	O
put	VBD	O
the	DT	O
lives	NNS	O
of	IN	O
adults	NNS	O
at	IN	O
risk	NN	O
drive	NN	B-REL
parents	NNS	O
to	TO	O
invest	VB	O
more	RBR	O
in	IN	O
caring	VBG	O
for	IN	O
their	PRP$	O
offspring	NN	O

positive	JJ	O
treatment	NN	O
expectancies	NNS	O
substantially	RB	B-REL
enhanced	VBD	I-REL
,	,	I-REL
in	IN	I-REL
fact	NN	I-REL
doubled	VBD	I-REL
,	,	O
the	DT	O
analgesic	JJ	O
benefit	NN	O
of	IN	O
remifentanil	NN	O

an	DT	O
individual	NN	O
's	POS	O
expectation	NN	O
of	IN	O
a	DT	O
drug	NN	O
's	POS	O
effect	NN	O
critically	RB	B-REL
influences	VBZ	I-REL
its	PRP$	O
therapeutic	JJ	O
efficacy	NN	O
and	CC	O
that	IN	O
regulatory	JJ	O
brain	NN	O
mechanisms	NNS	O
differ	VBP	O
as	IN	O
a	DT	O
function	NN	O
of	IN	O
expectancy	NN	O

positive	JJ	O
expectations	NNS	O
of	IN	O
treatment	NN	O
doubled	VBD	B-REL
the	DT	O
natural	JJ	O
physiological	JJ	O
or	CC	O
biochemical	JJ	O
effect	NN	O
of	IN	O
the	DT	O
opioid	JJ	O
drug	NN	O

selective-system	NN	O
schools	NNS	O
were	VBD	B-REL
no	RB	I-REL
more	RBR	I-REL
conducive	JJ	O
to	TO	O
mobility	NN	O

comprehensive	JJ	O
schools	NNS	O
were	VBD	B-REL
as	RB	I-REL
good	JJ	I-REL
for	IN	O
mobility	NN	O
as	IN	O
the	DT	O
selective	JJ	O
schools	NNS	O
they	PRP	O
replaced	VBD	O

those	DT	O
who	WP	O
went	VBD	O
to	TO	O
comprehensive	JJ	O
schools	NNS	O
were	VBD	B-REL
not	RB	I-REL
disadvantaged	JJ	I-REL
in	IN	O
terms	NNS	O
of	IN	O
social	JJ	O
mobility	NN	O
compared	VBN	O
with	IN	O
those	DT	O
who	WP	O
attended	VBD	O
grammar	NN	O
schools	NNS	O
and	CC	O
secondary	JJ	O
moderns	NNS	O

serotonin	NN	O
activity	NN	O
influences	VBZ	B-REL
the	DT	O
way	NN	O
people	NNS	O
make	VBP	O
judgments	NNS	O
about	IN	O
close	JJ	O
intimate	JJ	O
partnerships	NNS	O

central	JJ	O
serotonin	NN	O
activity	NN	O
influences	VBZ	B-REL
the	DT	O
appraisal	NN	O
of	IN	O
close	JJ	O
intimate	JJ	O
partnerships	NNS	O

The	DT	O
judgements	NNS	O
we	PRP	O
make	VBP	O
about	IN	O
the	DT	O
intimacy	NN	O
of	IN	O
other	JJ	O
couples	NNS	O
'	POS	O
relationships	NNS	O
are	VBP	B-REL
influenced	VBN	I-REL
by	IN	I-REL
the	DT	O
brain	NN	O
chemical	NN	O
serotonin	NN	O

Intravenously	RB	O
injected	VBN	O
RVG-targeted	JJ	O
exosomes	NNS	O
delivered	VBN	O
GAPDH	NNP	O
siRNA	NNP	O
specifically	RB	O
to	TO	O
neurons	NNS	O
,	,	O
microglia	NNS	O
,	,	O
oligodendrocytes	NNS	O
in	IN	B-REL
the	DT	O
brain	NN	O
,	,	O
resulting	VBG	B-REL
in	IN	O
a	DT	O
specific	JJ	O
gene	NN	O
knockdown	NN	O

The	DT	O
technique	NN	O
overcomes	VBZ	B-REL
the	DT	O
blood-brain	JJ	O
barrier	NN	O

social	JJ	O
proximity	NN	O
increased	VBD	B-REL
cooperative	JJ	O
investment	NN	O

Cost	NN	O
endured	VBD	O
was	VBD	O
positively	RB	O
correlated	VBN	B-REL
with	IN	I-REL
the	DT	O
strength	NN	O
of	IN	O
the	DT	O
social	JJ	O
tie	NN	O
between	IN	O
donor	NN	O
and	CC	O
recipient	JJ	O

People	NNS	O
will	MD	B-REL
suffer	VB	I-REL
more	JJR	I-REL
pain	NN	I-REL
for	IN	O
their	PRP$	O
close	JJ	O
friends	NNS	O
than	IN	O
for	IN	O
their	PRP$	O
acquaintances	NNS	O
and	CC	O
sometimes	RB	O
more	JJR	O
than	IN	O
they	PRP	O
would	MD	O
for	IN	O
themselves	PRP	O

When	WRB	O
put	VBN	O
to	TO	B-REL
the	DT	O
test	NN	O
we	PRP	B-REL
are	VBP	I-REL
actually	RB	I-REL
willing	JJ	I-REL
to	TO	O
do	VB	B-REL
more	JJR	I-REL
for	IN	O
our	PRP$	O
friends	NNS	O
than	IN	O
ourselves	PRP	O

The	DT	O
amount	NN	O
of	IN	O
flexibility	NN	O
in	IN	O
each	DT	O
participant	NN	O
could	MD	O
be	VB	O
used	VBN	O
to	TO	O
predict	VB	B-REL
that	IN	O
participant	NN	O
's	POS	O
learning	NN	O

Flexibility	NN	O
,	,	O
which	WDT	O
we	PRP	O
measure	VB	O
by	IN	O
the	DT	O
allegiance	NN	O
of	IN	O
nodes	NNS	O
to	TO	O
modules	NNS	O
,	,	O
in	IN	O
one	CD	O
experimental	JJ	O
session	NN	O
predicts	VBZ	B-REL
the	DT	O
relative	JJ	O
amount	NN	O
of	IN	O
learning	VBG	O
in	IN	O
a	DT	O
future	JJ	O
session	NN	O

how	WRB	O
different	JJ	O
areas	NNS	O
of	IN	O
the	DT	O
brain	NN	O
team	NN	O
up	RB	O
to	TO	B-REL
help	VB	I-REL
people	NNS	O
learn	VBP	O

...	:	O
the	DT	O
women	NNS	O
with	IN	O
dysmenorrhoea	NN	O
demonstrated	VBD	O
no	DT	B-REL
significant	JJ	I-REL
deactivations	NNS	I-REL
in	IN	O
response	NN	O
to	TO	O
stimulation	NN	O
of	IN	O
the	DT	O
arm	NN	O
and	CC	O
only	RB	O
of	IN	O
the	DT	O
occipital	JJ	O
cortex	NN	O
...	:	O

...	:	O
During	IN	O
menstruation	NN	O
,	,	O
deactivation	NN	B-REL
of	IN	I-REL
brain	NN	I-REL
regions	NNS	I-REL
in	IN	O
response	NN	O
to	TO	O
noxious	JJ	O
stimulation	NN	O
was	VBD	O
observed	VBN	O
in	IN	O
control	NN	O
women	NNS	O
but	CC	O
not	RB	O
in	IN	O
women	NNS	O
with	IN	O
dysmenorrhoea	NN	O
.	.	O

...	:	O
Women	NNS	O
with	IN	O
painful	JJ	O
periods	NNS	O
show	VBP	O
increased	VBN	B-REL
sensitivity	NN	I-REL
to	TO	O
pain	NN	O
...	:	O

SMT	NNP	O
C1100	NN	O
induces	VBZ	O
increased	VBN	O
levels	NNS	O
of	IN	O
utrophin	NN	O
RNA	NN	O
in	IN	O
human	JJ	O
muscle	NN	O
cells	NNS	O
and	CC	O
significantly	RB	B-REL
reduces	VBZ	I-REL
dystrophin-deficient	JJ	O
muscle	NN	O
pathology	NN	O

